Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionactin binding

PHACTR2 CTNNAL1 ACTR3C CD2AP PARVB DST FMN1 DMD ALDOA UTRN FKBP15 COBLL1 INO80 ACTR3B EGFR XIRP2 INF2 SIPA1L1 SCIN

8.03e-0747921019GO:0003779
GeneOntologyMolecularFunctioncytoskeletal protein binding

HAUS6 PHACTR2 CTNNAL1 MAP4 ACTR3C MARK3 CD2AP PARVB TTBK2 STX1A DST BRCA2 FMN1 ABCG2 DMD ALDOA UTRN TBCC FKBP15 KIF26B COBLL1 NUMA1 INO80 ACTR3B SETD2 EGFR XIRP2 INF2 SIPA1L1 SCIN

1.58e-06109921030GO:0008092
DomainSpectrin_repeat

TRIO DST DMD UTRN PPL

1.60e-05292095IPR002017
DomainSPEC

TRIO DST DMD UTRN PPL

2.63e-05322095SM00150
DomainSpectrin/alpha-actinin

TRIO DST DMD UTRN PPL

2.63e-05322095IPR018159
DomainSpectrin

TRIO DST DMD UTRN

1.14e-04232094PF00435
DomainPSP

SF3B2 ZCCHC8

1.25e-0422092SM00581
DomainPSP

SF3B2 ZCCHC8

1.25e-0422092IPR006568
DomainDystrophin

DMD UTRN

1.25e-0422092IPR016344
DomainPSP

SF3B2 ZCCHC8

1.25e-0422092PF04046
Pubmed

The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.

HAUS6 MAP4 CD2AP ECD NACA ZNF318 KIDINS220 PRRC2C AHNAK SEC16A SF3B2 RANBP2 KIF26B RTN4 ZDBF2 HEATR1 JMJD1C EGFR SUGP1 ANKRD17 GIGYF2 PRKDC

5.98e-192562122233397691
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

HAUS6 ILF3 MAP4 ECD NACA ZNF318 PDCD4 DST PRRC2C AHNAK SEC16A HELZ BOD1L1 ALDOA TASOR UTRN SF3B2 WDR44 FKBP15 RANBP2 NAA15 ZCCHC8 AHCTF1 RTN4 NUMA1 HEATR1 AKAP12 SETD2 PRPF3 SUGP1 ANKRD17 NCOA7 GIGYF2 PRKDC SCIN OGA

1.04e-189342123633916271
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

PHACTR2 TRIO MAP4 TEX2 MARK3 CD2AP CDK14 BCR FSIP2 DST PIK3C2A PIK3C3 PRRC2C AHNAK SEC16A HELZ BOD1L1 UTRN NAA15 KIF26B ZCCHC8 WWP2 COBLL1 C6orf132 MTMR4 PHF3 SIPA1L1 ANKRD17 NCOA7 GIGYF2 CRYBG3 PATJ PARD3

3.96e-178612123336931259
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

HAUS6 CTNNAL1 ILF3 MAP4 MARK3 CD2AP NARS1 KIDINS220 DST PRRC2C AHNAK SEC16A BOD1L1 SF3B2 RANBP2 COPA AHCTF1 COBLL1 RTN4 NUMA1 JMJD1C AKAP12 SF3B3 EGFR ANKRD17 GIGYF2 PRKDC CRYBG3 PATJ PARD3

8.31e-177082123039231216
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

MAP4 NARS1 CHD2 ZNF318 BIRC6 URB1 DST SUPT5H PRRC2C AHNAK SEC16A HELZ DDX24 UTRN SF3B2 RANBP2 NAA15 COPA ZCCHC8 AHCTF1 NUMA1 HEATR1 PHF3 PDCD11 ANKRD17 GIGYF2 PRKDC ZMYM3

7.13e-166532122822586326
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

TRERF1 HAUS6 ZNF280D CD2AP ZNF318 BCR BIRC6 DST BRCA2 AHNAK SEC16A TASOR UTRN RANBP2 ZCCHC8 ZDBF2 JMJD1C ZFHX4 ANKRD17 GIGYF2 CRYBG3 ZMYM3

1.78e-144182122234709266
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

ILF3 MAP4 CD2AP ZNF318 PRAM1 BRCA2 PRRC2C AHNAK SEC16A BOD1L1 ALDOA DDX24 TASOR SF3B2 RANBP2 AHCTF1 NUMA1 TOPBP1 ZDBF2 HEATR1 JMJD1C SETD2 SF3B3 PRPF3 PHF3 SUGP1 PDCD11 GIGYF2 PRKDC MRPL1

2.10e-139542123036373674
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

A2M ILF3 MAP4 MARK3 ECD NACA NARS1 PDCD4 TRMT10C DST PRRC2C AHNAK G3BP2 TRMT1L ALDOA DDX24 SF3B2 NAA15 COPA AHCTF1 PARP2 NUMA1 HEATR1 ZFC3H1 PPL SF3B3 EGFR PRPF3 PHF3 SIPA1L1 PDCD11 ANKRD17 PRKDC PATJ

3.21e-1312572123436526897
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

TRERF1 ILF3 MAP4 KDM5C ZNF318 SEC16A HELZ DDX24 SF3B2 WDR44 RANBP2 COPA ZCCHC8 NUMA1 PPL PACS1 SETD2 EGFR PHF3 SIPA1L1 ANKRD17 GIGYF2 ELK3 PRKDC PARD3 OGA ZMYM3

3.36e-137742122715302935
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

MAP4 MARK3 CD2AP NACA MAML1 CHD2 ZNF318 DENND2D URB1 TRMT10C KIDINS220 DST PIK3C2A SUPT7L HELZ TRMT1L TAF5 TASOR UTRN RANBP2 ZCCHC8 AHCTF1 PARP2 TOPBP1 HEATR1 INO80 ZFC3H1 C6orf132 SETD2 PPP2R5E PHF3 SIPA1L1 PDCD11 ANKRD17 PATJ PARD3 ZMYM3

3.80e-1314972123731527615
Pubmed

RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.

ILF3 MAP4 URB1 KIDINS220 PIK3C2A PRRC2C FKBP15 RANBP2 NUMA1 HEATR1 ZFC3H1 SF3B3 PDCD11 GIGYF2 PRKDC

2.27e-122022121524639526
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

A2M ERBB3 NACA BCR DST SUPT5H PRRC2C PIP5K1A HELZ METTL16 TASOR SF3B2 NAA15 RTN4 DOCK10 JMJD1C PACS1 GRPEL1 NEMF ANKRD17 GIGYF2 CRYBG3 CLSPN PATJ

2.31e-126502122438777146
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

HAUS6 ILF3 ABCF3 MAP4 CD2AP BCR URB1 PIK3C2A PRRC2C AHNAK G3BP2 PIP5K1A HELZ DDX24 RANBP2 COPA RTN4 INO80 ZFC3H1 AKAP12 CCNB1 SF3B3 PHF3 ANKRD17 GIGYF2

3.35e-127242122536232890
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

TRIO MAP4 ACTR3C MARK3 CD2AP CHD2 PARVB CDK14 BCR MAP3K12 DNAH14 TMCO4 TNRC18 STX3 KIDINS220 PIK3C3 NGEF PIP5K1A BOD1L1 UTRN PRUNE2 WWP2 KAT6A AHCYL2 JMJD1C HIVEP3 PACS1 EGFR INF2 PRPF3 NEMF ANKRD17 ELK3 PATJ PARD3

7.31e-1214892123528611215
Pubmed

Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.

HAUS6 KDM5C ECD NACA ZNF318 PRRC2C AHNAK PIP5K1A ALDOA TASOR JMJD1C SBNO1 ANKRD17 GIGYF2 CLSPN

3.02e-112422121534011540
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

HAUS6 MAP4 CD2AP ZNF318 PRRC2C AHNAK SEC16A BOD1L1 TAF5 WDR44 AHCTF1 NUMA1 HEATR1 JMJD1C SETD2 PHF3 PDCD11 GIGYF2 PRKDC PATJ PARD3

3.07e-115492122138280479
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

ILF3 CHD2 ZNF318 URB1 DST SUPT5H AHNAK SUPT7L TAF5 DDX24 TASOR SF3B2 RANBP2 COPA ZCCHC8 AHCTF1 PARP2 NUMA1 TOPBP1 HEATR1 INO80 ZFC3H1 JMJD1C SETD2 SF3B3 PRPF3 PHF3 PDCD11 ASXL2 PRKDC ZMYM3

8.37e-1112942123130804502
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

A2M ILF3 TRIO ACTR3C TEX2 PDCD4 FMN1 PRRC2C NGEF TRMT1L RANBP2 NAA15 COPA ACAD10 INO80 ACTR3B SIPA1L1 NEMF PARD3

1.32e-104752121931040226
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

ILF3 ABCF3 MAP4 MARK3 NARS1 PDCD4 TNRC18 PIK3C2A G3BP2 SEC16A MLLT3 TRMT1L ALDOA DDX24 SF3B2 RANBP2 SELENBP1 COPA WWP2 RTN4 NUMA1 SF3B3 INF2 PHF3 SIPA1L1 NEMF ANKRD17 PRKDC PATJ PARD3

1.58e-1012472123027684187
Pubmed

Human transcription factor protein interaction networks.

TRERF1 SOX5 NACA MAML1 ZNF318 DST PRRC2C G3BP2 SUPT7L SEC16A HELZ TRMT1L TAF5 DDX24 COPA DNAH10 NUMA1 INO80 JMJD1C GRPEL1 ZFHX4 SUGP1 PDCD11 ANKRD17 GIGYF2 ASXL2 ELK3 SUFU MRPL1 ZMYM3 RAI2 MYB

2.19e-1014292123235140242
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

ILF3 ABCF3 MAP4 NACA NARS1 CHD2 BIRC6 URB1 DST PIK3C2A AHNAK SEC16A ALDOA DDX24 UTRN SF3B2 RANBP2 NAA15 COPA AHCTF1 NUMA1 DOCK10 HEATR1 SF3B3 INF2 PRPF3 PDCD11 ANKRD17 PRKDC PARD3 ZMYM3

2.49e-1013532123129467282
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

MARK3 ECD NACA NARS1 PDCD4 URB1 TRMT10C STX3 DST PIK3C2A PRRC2C AHNAK G3BP2 TRMT1L ALDOA DDX24 RANBP2 COPA ZCCHC8 PARP2 RTN4 NUMA1 HEATR1 CCNB1 SF3B3 INF2 PRPF3 SIPA1L1 PDCD11 PRKDC IKBKB MRPL1

2.65e-1014402123230833792
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

PHACTR2 ILF3 ZNF658 ECD CHD2 ZNF318 TNRC18 STX3 DST SACS PRRC2C AHNAK BOD1L1 DMD TASOR PLXNA3 RANBP2 RARG COPA PCDHGA2 PCLO NUMA1 AHCYL2 HEATR1 ZFC3H1 SH3D21 PPL GRPEL1 SF3B3 SBNO1 PRKDC CFAP46

2.75e-1014422123235575683
Pubmed

A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.

A2M CTNNAL1 ECD BCR TRMT10C KIDINS220 SUPT5H SEC16A PIP5K1A HELZ DMD UTRN SF3B2 FKBP15 RANBP2 TMEM186 NAA15 RTN4 HEATR1 PPL CCNB1 MTMR4 ANKRD17 PRKDC CDC25A SUFU

3.34e-109742122628675297
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

MAP4 MARK3 NACA BIRC6 URB1 PIK3C3 PRRC2C G3BP2 TRMT1L DDX24 TASOR COPA RNPC3 KAT6A NUMA1 TOPBP1 HEATR1 ZFC3H1 PRPF3 PHF3 NEMF PDCD11 PRKDC

3.36e-107592122335915203
Pubmed

E-cadherin interactome complexity and robustness resolved by quantitative proteomics.

ERBB3 PHACTR2 ABCF3 MAP4 MARK3 CD2AP KIDINS220 DST FMN1 AHNAK ALDOA UTRN COBLL1 RTN4 PPL C6orf132 EGFR GIGYF2 PATJ PARD3

3.59e-105652122025468996
Pubmed

The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.

ILF3 ABCF3 TRIO MAP4 PRRC2C AHNAK G3BP2 DMD COPA JMJD1C INF2 SUGP1 ANKRD17 LTBP1 PRKDC

5.53e-102982121530737378
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

HAUS6 ILF3 CD2AP ECD NACA TTBK2 URB1 AHNAK PDCL3 ABCG2 SF3B2 RANBP2 NAA15 COPA AHCTF1 NUMA1 TOPBP1 PPL AKAP12 CCNB1 PACS1 PPP2R5E SF3B3 INF2 PRPF3 ASXL2 PRKDC ZMYM3

5.78e-1011552122820360068
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

ILF3 TEX2 MARK3 ECD URB1 TRMT10C KIDINS220 PIK3C2A SACS DNAJC12 PIP5K1A DDX24 SF3B2 TMEM186 PDPR NAA15 ERO1B WWP2 AHCTF1 RTN4 HEATR1 ZFC3H1 AKAP12 GRPEL1 SF3B3 EGFR INF2 PDCD11 CRYBG3 PARD3 OGA MRPL1

5.87e-1014872123233957083
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

TRIO TEX2 ECD BCR KIDINS220 DST SEC16A UTRN KIF26B ZDBF2 SIPA1L1 CRYBG3 SUFU

6.19e-102092121336779422
Pubmed

Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.

ERBB3 MARK3 STX3 KIDINS220 DST FMN1 PIP5K1A DMD UTRN WDR44 FERMT3 KIF26B WWP2 DOCK10 AKAP12 PACS1

1.72e-093772121638117590
Pubmed

Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.

MAP4 KDM5C NARS1 PDCD4 SUPT5H AHNAK BOD1L1 TRMT1L SF3B2 RANBP2 COPA NUMA1 PHF3 PRKDC ZMYM3

2.42e-093322121532786267
Pubmed

Spatial proteomics reveal that the protein phosphatase PTP1B interacts with and may modify tyrosine phosphorylation of the rhomboid protease RHBDL4.

MAP4 TEX2 CD2AP DST AHNAK SEC16A RANBP2 RTN4 JMJD1C AKAP12 EGFR INF2

2.56e-091912121231177093
Pubmed

Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.

ILF3 MAP4 ZNF318 SUPT5H BOD1L1 TRMT1L SF3B2 AHCTF1 NUMA1 JMJD1C PRPF3 PHF3 SUGP1 PRKDC

2.63e-092832121430585729
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

DDX59 ILF3 ABCF3 MAP4 ECD NACA NARS1 BIRC6 PDCD4 TRMT10C PRRC2C AHNAK G3BP2 SEC16A TRMT1L ALDOA DDX24 SF3B2 RANBP2 NAA15 COPA NUMA1 AHCYL2 SF3B3 EGFR SBNO1 PRPF3 NEMF GIGYF2 PRKDC

3.03e-0914152123028515276
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

CTNNAL1 ABCF3 MAP4 TEX2 CD2AP CHD2 ZNF318 TTBK2 URB1 FMN1 SEC16A BOD1L1 TASOR UTRN AHCTF1 HEATR1 INO80 AKAP12 PACS1 PPP2R5E INF2 SIPA1L1 ANKRD17 ASXL2 PATJ PARD3

3.13e-0910842122611544199
Pubmed

MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.

MAML1 ZNF318 SUPT7L DDX24 TASOR SF3B2 ZCCHC8 ZDBF2 JMJD1C SBNO1 PRPF3 SUGP1 PDCD11 CLSPN OGA

3.21e-093392121530415952
Pubmed

Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.

ILF3 ABCF3 MAP4 NACA PDCD4 SUPT5H G3BP2 TRMT1L ALDOA SF3B2 WDR44 NAA15 COPA RTN4 NUMA1 SF3B3 SBNO1 PRPF3 NEMF PRKDC

4.26e-096532122033742100
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

KDM5C MAML1 ZNF318 BCR BRCA2 SUPT5H PRRC2C SEC16A HELZ ZCCHC8 TOPBP1 ZDBF2 SETD2 SF3B3 CRYBG3 CLSPN PATJ SCIN ZMYM3

4.47e-095882121938580884
Pubmed

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

CHD2 BIRC6 SUPT5H PRRC2C AHNAK BOD1L1 TRMT1L TTC5 TASOR UNC79 LRRC8E RANBP2 ZCCHC8 AHCTF1 NUMA1 PARP14 CCNB1

5.59e-094692121727634302
Pubmed

Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.

A2M ABCF3 MAP4 CD2AP NACA TRMT10C PIK3C2A SUPT5H AHNAK G3BP2 SEC16A PIP5K1A ALDOA DDX24 UTRN SF3B2 RANBP2 PDPR NAA15 COPA RTN4 PPL AKAP12 GRPEL1 SF3B3 INF2 PDCD11 ANKRD17 PRKDC

5.64e-0913672122932687490
Pubmed

Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.

MAP4 NACA CHD2 KIDINS220 BOD1L1 ALDOA COPA DOCK10 PPL PHF3 SIPA1L1 ANKRD17

6.71e-092082121233230847
Pubmed

Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.

HAUS6 MAP4 CD2AP NACA AHNAK TRMT1L TASOR UTRN SF3B2 ANKRD17 GIGYF2 OGA

9.71e-092152121235973513
Pubmed

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

HAUS6 ZNF318 KIDINS220 SEC16A HELZ UTRN RANBP2 AHCTF1 JMJD1C C6orf132 GIGYF2 CRYBG3 PARD3

9.98e-092632121334702444
Pubmed

Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.

ILF3 URB1 G3BP2 TRMT1L DDX24 TASOR SF3B2 RANBP2 ZCCHC8 AHCTF1 NUMA1 HEATR1 INO80 ZFC3H1 SF3B3 PRPF3 PHF3 PDCD11 ANKRD17 GIGYF2 PRKDC ZMYM3

1.37e-088472122235850772
Pubmed

Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

PHACTR2 G3BP2 ATP2C2 FKBP15 DOCK10 MTMR4 ANKRD17 GIGYF2 OGA

1.37e-0810221299734811
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

ILF3 ZNF280D TRIO MAP4 NACA CMYA5 URB1 TRMT10C KIDINS220 SUPT5H G3BP2 KCTD16 BOD1L1 ALDOA DDX24 SF3B2 RANBP2 COPA DNAH10 PCLO RTN4 NUMA1 HEATR1 SF3B3 SBNO1 NEMF PDCD11 GIGYF2 PRKDC

1.41e-0814252122930948266
Pubmed

Defining the membrane proteome of NK cells.

ILF3 ABCF3 BCR BIRC6 KIDINS220 PIK3C2A PIK3C3 PRRC2C AHNAK HELZ ALDOA DDX24 FERMT3 FKBP15 RANBP2 NAA15 COPA WWP2 DOCK10 HEATR1 PARP14 EIF4EBP3 ANKRD17 GIGYF2 PRKDC OGA

1.43e-0811682122619946888
Pubmed

Defining the human deubiquitinating enzyme interaction landscape.

MARK3 BCR PDCD4 TRMT10C PIK3C2A G3BP2 SUPT7L ALDOA DDX24 UTRN SELENBP1 COPA AHCYL2 USP37 PRPF3 SIPA1L1 EIF4EBP3 ANKRD17 GIGYF2 ABCC12 ASXL2 CDC25A LONRF2 OGA

1.44e-0810052122419615732
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

ILF3 TRIO MAP4 ACTR3C MARK3 NARS1 BCR KIDINS220 DST SACS PRRC2C G3BP2 AKR1B10 NGEF SEC16A DMD ALDOA UTRN SELENBP1 OXR1 COPA PCLO RTN4 ACTR3B PACS1 PPP2R5E SF3B3 INF2 SIPA1L1

1.54e-0814312122937142655
Pubmed

Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.

MAP4 TEX2 CD2AP TMCO4 DST PRRC2C AHNAK SEC16A WDR44 RANBP2 AHCTF1 RTN4 NUMA1 ZDBF2 AKAP12 EGFR INF2 GIGYF2

1.56e-085682121837774976
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

HAUS6 ILF3 MAP4 KDM5C PDCD4 SEC16A DDX24 WDR44 RANBP2 COPA ZCCHC8 WWP2 AHCTF1 COBLL1 NUMA1 TOPBP1 PHF3

1.56e-085032121716964243
Pubmed

LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.

HAUS6 ILF3 TRMT10C PIK3C2A PRRC2C SEC16A HELZ DDX24 SF3B2 PCLO AKAP12 CCNB1 PPP2R5E PRPF3 EIF4EBP3 ANKRD17 GIGYF2 PRKDC CLSPN

1.69e-086392121923443559
Pubmed

Identification of proximal SUMO-dependent interactors using SUMO-ID.

ILF3 ABCF3 MAP4 CD2AP ZNF318 BRCA2 AHNAK SEC16A ALDOA RANBP2 RTN4 JMJD1C SBNO1 PRPF3 PHF3 SUGP1

1.73e-084442121634795231
Pubmed

The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.

TRIO KDM5C TNRC18 DST SACS PRRC2C AHNAK SEC16A COPA AHCTF1 KAT6A NUMA1 PARP14 PRKDC

1.99e-083322121437433992
Pubmed

A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.

ILF3 NACA PDCD4 PIK3C2A PDCL3 HELZ SF3B2 RANBP2 USP37 SIPA1L1 CLSPN CDC25A

2.26e-082322121225515538
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

A2M ILF3 MAP4 MARK3 NACA NARS1 CHD2 TRMT10C PIK3C2A PRRC2C AHNAK G3BP2 AKR1B10 SEC16A ALDOA SF3B2 COPA WWP2 AHCTF1 COBLL1 NUMA1 FCF1 GRPEL1 PHF3 NEMF PDCD11 ANKRD17 PARD3

2.38e-0813712122836244648
Pubmed

WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.

CD2AP CHD2 AHNAK PIP5K1A TAF5 DDX24 UTRN RANBP2 PARP2 NUMA1 INO80 PRPF3 PDCD11 PRKDC ZMYM3

2.39e-083942121527248496
Pubmed

The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.

TRERF1 ERBB3 NACA PRAM1 TRMT10C PCDH15 DDX24 PDPR COPA PCLO INO80 PPP2R5E PRPF3 SUGP1 PRKDC

2.55e-083962121526687479
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

TRIO TEX2 NACA MAML1 BCR BIRC6 SEC16A HELZ BOD1L1 TASOR SF3B2 FKBP15 ZDBF2 JMJD1C SETD2 MTMR4 PHF3 SUGP1 CLSPN PATJ

2.90e-087332122034672954
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

CTNNAL1 TRIO BIRC6 TRMT10C SUPT5H AHNAK SEC16A HELZ DMD UTRN RANBP2 PDPR COPA PACS1 GRPEL1 MTMR4 PPP2R5E EGFR PRPF3 LTBP1 CRYBG3 CDC25A SUFU SCIN

3.22e-0810492122427880917
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

MAP4 TEX2 DST PIK3C2A SACS G3BP2 NGEF ALDOA OXR1 PCLO RTN4 AHCYL2 SIPA1L1 GIGYF2

3.46e-083472121417114649
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

TRIO MAP4 ACTR3C TEX2 NACA BCR BIRC6 TRMT10C STX1A TNRC18 PRRC2C G3BP2 KCTD16 HELZ ALDOA FKBP15 RANBP2 NAA15 PCLO RTN4 ZDBF2 AHCYL2 ACTR3B SIPA1L1 CRYBG3

3.64e-0811392122536417873
Pubmed

BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

ILF3 MAP4 NACA NARS1 CHD2 PARVB PDCD4 TRMT10C AHNAK SEC16A HELZ TRMT1L TAF5 DDX24 SF3B2 FERMT3 RANBP2 COPA AHCTF1 PARP2 NUMA1 HEATR1 FCF1 SF3B3 PDCD11 PRKDC MRPL1

4.07e-0813182122730463901
Pubmed

Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.

NACA ZNF318 BRCA2 SUPT5H ALDOA SF3B2 RANBP2 NUMA1 TOPBP1 SF3B3 SBNO1 PRPF3 PRKDC CLSPN

4.92e-083572121437059091
Pubmed

LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.

TRIO MAP4 PRRC2C AHNAK SEC16A COPA NUMA1 PARP14 EGFR ANKRD17 PRKDC

5.23e-082022121133005030
Pubmed

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.

CD2AP NACA DST PRRC2C AHNAK SEC16A UTRN SF3B2 NUMA1 PPL AKAP12 PACS1 PRPF3 PRKDC

5.45e-083602121433111431
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

PHACTR2 CTNNAL1 TRIO MARK3 KIDINS220 DST SEC16A PIP5K1A DMD UTRN AKAP12 PACS1 EGFR INF2 PARD3

5.68e-084212121536976175
Pubmed

An improved smaller biotin ligase for BioID proximity labeling.

MAP4 ZNF318 FSIP2 DST PRRC2C PDCL3 NGEF RANBP2 JMJD1C

7.07e-08123212926912792
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

HAUS6 BIRC6 TNRC18 SACS TASOR PRUNE2 RNPC3 COBLL1 ZNF407 ZFC3H1 USP37 JMJD1C HIVEP3 SETD2 DNAH17 SCIN

7.31e-084932121615368895
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

ILF3 MAP4 KDM5C NARS1 CHD2 SUPT5H AHNAK BOD1L1 TRMT1L METTL16 SF3B2 FKBP15 RANBP2 COPA NUMA1 GINS4 INO80 SETD2 SF3B3 SBNO1 PRPF3 PHF3 PRKDC

7.42e-0810142122332416067
Pubmed

Transcription factor Foxp3 and its protein partners form a complex regulatory network.

MAP4 CD2AP PDCD4 HELZ TRMT1L RANBP2 ZCCHC8 AHCTF1 TOPBP1 HEATR1 CCNB1 PHF3 SIPA1L1 SUGP1

7.64e-083702121422922362
Pubmed

Comparative interactome analysis of α-arrestin families in human and Drosophila.

KDM5C ECD BCR KIDINS220 BOD1L1 ABCG2 DMD UTRN COPA ZCCHC8 WWP2 NUMA1 PARD3

7.71e-083132121338270169
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

TRIO CHD2 CMYA5 BIRC6 DST PIK3C2A ALDOA UTRN RANBP2 ZNF407 JMJD1C AKAP12 CCNB1 PPP2R5E XIRP2 PARD3

8.16e-084972121623414517
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

ERBB3 TRIO NARS1 PARVB CMYA5 RYR3 STX1A DST SACS SUPT5H NGEF MLLT3 ALDOA UTRN SF3B2 RARB OXR1 COPA ZCCHC8 ZFC3H1 ACTR3B PPP2R5E SBNO1 SIPA1L1 NEMF PRKDC

9.46e-0812852122635914814
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

KDM5C ZNF318 BCR SUPT7L SEC16A HELZ TAF5 DDX24 ZCCHC8 AHCTF1 KAT6A INO80 SETD2 PPP2R5E SF3B3 ZFHX4 CCNB3 PRPF3 SIPA1L1 ANKRD17 CRYBG3 CLSPN PARD3 ZMYM3

1.01e-0711162122431753913
Pubmed

Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.

PHACTR2 ZNF318 DST PDCL3 BOD1L1 UTRN SF3B2 ZCCHC8 AHCTF1 COBLL1 NUMA1 SF3B3 INF2 PRPF3 PHF3 SUGP1

1.04e-075062121630890647
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

TRERF1 ILF3 TRIO ZNF318 BCR DST PRRC2C G3BP2 KCTD16 NGEF SEC16A TAF5 UNC79 FERMT3 FKBP15 RANBP2 NUMA1 AKAP12 SIPA1L1 ANKRD17 GIGYF2 PARD3

1.28e-079632122228671696
Pubmed

Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.

CTNNAL1 MAP4 CD2AP ECD NACA KIDINS220 AHNAK SEC16A UTRN COPA RTN4 AKAP12 ANKRD17 GIGYF2 PRKDC

1.31e-074492121531732153
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

ILF3 MAP4 CHD2 URB1 TRMT10C SUPT5H PRRC2C G3BP2 HELZ METTL16 ALDOA DDX24 SF3B2 HEATR1 PRPF3 SUGP1 PDCD11 GIGYF2 PRKDC MRPL1

1.37e-078072122022681889
Pubmed

In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.

ILF3 MAP4 NACA TRMT10C PRRC2C G3BP2 PIP5K1A TRMT1L ALDOA DDX24 SF3B2 COPA USP37 CCNB1 SF3B3 PRPF3 PDCD11 ANKRD17 CLSPN CDC25A SCIN MRPL1

1.48e-079712122233306668
Pubmed

Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.

URB1 AHNAK SF3B2 FERMT3 RANBP2 COPA AHCTF1 PARP14 C6orf132 SF3B3 PHF3 PDCD11 PRKDC

2.00e-073402121329478914
Pubmed

PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.

ILF3 MAP4 AHNAK SF3B2 FKBP15 COPA ZCCHC8 RTN4 NUMA1 PARP14 SF3B3 EGFR PRKDC

2.00e-073402121324332808
Pubmed

Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.

HAUS6 MAP4 ZNF318 PIK3C2A SEC16A JMJD1C CCNB1 SF3B3 SIPA1L1 GIGYF2

2.18e-071842121032908313
Pubmed

PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.

ILF3 MARK3 NACA PRRC2C G3BP2 SEC16A PIP5K1A HELZ TRMT1L DDX24 SF3B2 ZCCHC8 SF3B3 PRPF3 PDCD11 ANKRD17 GIGYF2 MRPL1

2.20e-076782121830209976
Pubmed

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

ILF3 DST AHNAK NGEF DMD DDX24 SF3B2 COBLL1 NUMA1 SF3B3 GIGYF2

2.31e-072342121136243803
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

ILF3 CHD2 TRMT10C KIDINS220 DST SACS SUPT5H PCDH15 DDX24 SF3B2 FKBP15 RANBP2 COPA ZCCHC8 RNPC3 INO80 SETD2 SF3B3 PRPF3 NEMF SUGP1 PRKDC ZMYM3

2.34e-0710822122338697112
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

MARK3 KIDINS220 PRRC2C SEC16A BOD1L1 FKBP15 DOCK10 AHCYL2 PPP2R5E PHF3 SIPA1L1 GIGYF2 ASXL2 ZMYM3

2.44e-074072121412693553
Pubmed

WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.

ILF3 MAP4 NACA PDCD4 SUPT5H PRRC2C G3BP2 TRMT1L SF3B2 WWP2 NUMA1 SF3B3 NEMF ANKRD17 GIGYF2 PRKDC PATJ

2.76e-076152121731048545
Pubmed

Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.

ILF3 MAP4 MARK3 NACA PRRC2C G3BP2 TRMT1L DDX24 PARP2 ZFC3H1 PRPF3 RNF146 NEMF PDCD11 PRKDC

3.58e-074862121530940648
Pubmed

The ubiquitin E3 ligase ARIH1 regulates hnRNP E1 protein stability, EMT and breast cancer progression.

MAP4 CD2AP NACA AHNAK SF3B3 GIGYF2 PRKDC

3.60e-0774212735102251
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

ILF3 MAP4 NACA ZNF318 URB1 DST SACS SUPT5H AHNAK SEC16A UTRN SF3B2 RANBP2 COPA NUMA1 HEATR1 SF3B3 PRPF3 PDCD11 GIGYF2 PRKDC SCIN

3.64e-0710242122224711643
Pubmed

TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.

ILF3 MAP4 MARK3 NACA PDCD4 DST AHNAK G3BP2 ALDOA SDC2 SF3B2 COPA AHCTF1 PARP2 NUMA1 HEATR1 FCF1 SF3B3 PRPF3 PDCD11 PRKDC

4.23e-079492122136574265
Pubmed

A High-Density Human Mitochondrial Proximity Interaction Network.

ILF3 TEX2 BIRC6 TRMT10C DST PIK3C2A G3BP2 PDCL3 SEC16A DDX24 WDR44 PDPR NAA15 COPA ZCCHC8 AHCTF1 PCLO RTN4 ZDBF2 AHCYL2 HEATR1 CCNB1 GRPEL1 INF2 PDCD11 CRYBG3 MRPL1

5.02e-0714962122732877691
Pubmed

Oct4 links multiple epigenetic pathways to the pluripotency network.

ILF3 NACA AHNAK HELZ RTN4 NUMA1 JMJD1C PHF3 ANKRD17 GIGYF2

5.39e-072032121022083510
Pubmed

Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.

DDX59 ILF3 ZNF318 SUPT5H G3BP2 SEC16A TRMT1L RANBP2 NUMA1 ZFC3H1 SETD2 PRPF3 PHF3 ANKRD17

6.19e-074402121434244565
Pubmed

Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.

HAUS6 DDX59 ILF3 MARK3 KDM5C NARS1 CDK14 BIRC6 SEC16A HELZ METTL16 ZDBF2 HEATR1 SETD2 PPP2R5E SF3B3 SBNO1 SUGP1 ANKRD17 GIGYF2 LTBP1 CLSPN CDC25A OGA SDHAF4

6.36e-0713272122532694731
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

ILF3 MAP4 CD2AP NACA NARS1 DST PRRC2C AHNAK G3BP2 SEC16A TRMT1L ALDOA SF3B2 RANBP2 NAA15 COPA AKAP12 SF3B3 NEMF ANKRD17 PRKDC PATJ OGA

6.61e-0711492122335446349
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

MARK3 BIRC6 DST PIK3C2A SEC16A HELZ UTRN FKBP15 ZCCHC8 SIPA1L1 GIGYF2 PRKDC PATJ PARD3

7.27e-074462121424255178
Pubmed

The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.

TRIO DST PIK3C3 SUPT5H HELZ TASOR ZFC3H1 SIPA1L1 NEMF ANKRD17

8.01e-072122121033853758
InteractionKCNA3 interactions

HAUS6 CTNNAL1 ILF3 MAP4 MARK3 CD2AP NACA NARS1 CHD2 KIDINS220 DST PRRC2C AHNAK SEC16A BOD1L1 ALDOA SF3B2 RANBP2 COPA AHCTF1 COBLL1 RTN4 NUMA1 DOCK10 JMJD1C PPL AKAP12 SF3B3 EGFR PHF3 SIPA1L1 ANKRD17 GIGYF2 PRKDC CRYBG3 PATJ PARD3

3.03e-1387121137int:KCNA3
InteractionPHLPP1 interactions

HAUS6 MAP4 CD2AP ECD NACA ZNF318 CMYA5 KIDINS220 PRRC2C AHNAK SEC16A SF3B2 RANBP2 KIF26B RTN4 ZDBF2 HEATR1 JMJD1C EGFR SUGP1 ANKRD17 GIGYF2 PRKDC

9.41e-1333321123int:PHLPP1
InteractionNAA40 interactions

HAUS6 ILF3 MAP4 ECD NACA ZNF318 PDCD4 DST PRRC2C AHNAK SEC16A HELZ BOD1L1 ALDOA TASOR UTRN SF3B2 WDR44 FKBP15 RANBP2 NAA15 ZCCHC8 AHCTF1 PARP2 RTN4 NUMA1 HEATR1 AKAP12 SETD2 PRPF3 SUGP1 ANKRD17 NCOA7 GIGYF2 PRKDC SCIN OGA

9.40e-1297821137int:NAA40
InteractionSIRT7 interactions

MAP4 NARS1 CHD2 ZNF318 BIRC6 URB1 DST SUPT5H PRRC2C AHNAK SEC16A HELZ DDX24 UTRN NR0B2 SF3B2 RANBP2 NAA15 COPA ZCCHC8 AHCTF1 NUMA1 HEATR1 CCNB1 PHF3 PDCD11 ANKRD17 GIGYF2 PRKDC ZMYM3

2.43e-1074421130int:SIRT7
InteractionNUP43 interactions

ZNF280D MAP4 KDM5C ZNF318 FSIP2 DST BRCA2 PRRC2C PDCL3 NGEF BOD1L1 TRMT1L DDX24 RANBP2 AHCTF1 TOPBP1 ZDBF2 HEATR1 INO80 ZFC3H1 JMJD1C SETD2 EGFR PDCD11 ASXL2 ZMYM3

2.24e-0962521126int:NUP43
InteractionTERF2IP interactions

KDM5C ZNF318 PDCD4 BRCA2 SUPT5H AKR1B10 SUPT7L BOD1L1 DDX24 TASOR SF3B2 ZCCHC8 AHCTF1 NUMA1 TOPBP1 SETD2 PPP2R5E SBNO1 PHF3 SUGP1 IKBKB CLSPN EPAS1 ZMYM3

4.13e-0955221124int:TERF2IP
InteractionWDHD1 interactions

MAP4 CD2AP BRCA2 SF3B2 SELENBP1 COPA GINS4 USP37 AKAP12 EGFR GIGYF2 CLSPN MRPL1 ZMYM3

5.53e-0917721114int:WDHD1
InteractionPOU5F1 interactions

SOX5 ERBB3 ILF3 NACA PRAM1 TRMT10C AHNAK PCDH15 HELZ DDX24 PDPR COPA ZCCHC8 WWP2 RTN4 NUMA1 INO80 JMJD1C PRPF3 PHF3 SUGP1 ANKRD17 GIGYF2 PRKDC

1.23e-0858421124int:POU5F1
InteractionYWHAH interactions

PHACTR2 ILF3 TRIO TEX2 MARK3 CD2AP CDK14 BCR PDCD4 DST PIK3C2A PIK3C3 PRRC2C AHNAK SEC16A BOD1L1 UTRN KIF26B ZCCHC8 COBLL1 C6orf132 PACS1 GRPEL1 MTMR4 PHF3 SIPA1L1 ANKRD17 NCOA7 GIGYF2 CRYBG3 PATJ PARD3 CDC25A

4.74e-08110221133int:YWHAH
InteractionRCOR1 interactions

SOX5 HAUS6 CD2AP ZNF318 BCR BIRC6 DST BRCA2 AHNAK SEC16A TASOR UTRN RANBP2 ZCCHC8 NUMA1 ZDBF2 JMJD1C ZFHX4 ANKRD17 GIGYF2 ZMYM3

6.01e-0849421121int:RCOR1
InteractionSNRNP40 interactions

ILF3 ZNF280D ECD ZNF318 URB1 BRCA2 SUPT5H G3BP2 TRMT1L DDX24 TASOR RNPC3 AHCTF1 KAT6A NUMA1 ZDBF2 HEATR1 ZFC3H1 USP37 SETD2 EGFR PRPF3 SUGP1 PDCD11

6.35e-0863721124int:SNRNP40
InteractionLGR4 interactions

ILF3 MAP4 URB1 KIDINS220 PIK3C2A PRRC2C FKBP15 RANBP2 NUMA1 HEATR1 ZFC3H1 SF3B3 PDCD11 GIGYF2 PRKDC

1.19e-0726221115int:LGR4
InteractionAURKB interactions

HAUS6 CMYA5 BRCA2 PRRC2C AHNAK G3BP2 SEC16A TRMT1L DDX24 TXNDC2 UTRN RANBP2 KIAA1586 USP37 GRPEL1 SETD2 EGFR INF2 PRPF3 EIF4EBP3 ANKRD17 GIGYF2 PRKDC CRYBG3 CDC25A MRPL1

1.20e-0776121126int:AURKB
InteractionPHF21A interactions

HAUS6 ZNF318 BCR BIRC6 DST BRCA2 AHNAK SEC16A UTRN RANBP2 ZCCHC8 ZDBF2 JMJD1C ZFHX4 GIGYF2 CRYBG3 ZMYM3

1.35e-0734321117int:PHF21A
InteractionHDAC1 interactions

TRERF1 HAUS6 KDM5C CD2AP ZNF318 BCR BIRC6 TNRC18 DST BRCA2 AHNAK PDCL3 TASOR UTRN NR0B2 SF3B2 RANBP2 RARB ZCCHC8 WWP2 PARP2 ZDBF2 USP37 JMJD1C CCNB1 ZFHX4 EGFR ANKRD17 GIGYF2 CRYBG3 EPAS1 ZMYM3

1.77e-07110821132int:HDAC1
InteractionSMC5 interactions

ILF3 MAP4 CD2AP ZNF318 PRAM1 BRCA2 PRRC2C AHNAK SEC16A BOD1L1 ALDOA DDX24 TASOR SF3B2 RANBP2 AHCTF1 NUMA1 TOPBP1 ZDBF2 HEATR1 JMJD1C SETD2 SF3B3 PRPF3 PHF3 SUGP1 PDCD11 GIGYF2 PRKDC MRPL1

2.01e-07100021130int:SMC5
InteractionSUMO2 interactions

MAP4 KDM5C NACA NARS1 PDCD4 DST SUPT5H AHNAK BOD1L1 TRMT1L ALDOA SF3B2 RANBP2 SELENBP1 COPA NUMA1 EGFR PHF3 ELK3 PRKDC ZMYM3 MYB

2.86e-0759121122int:SUMO2
InteractionEZR interactions

HAUS6 ERBB3 CTNNAL1 MARK3 ECD BCR KIDINS220 DST AHNAK SEC16A UTRN SDC2 WDR44 COBLL1 AHCYL2 PPL AKAP12 C6orf132 EGFR NEMF OGA

3.92e-0755321121int:EZR
InteractionHMGA1 interactions

TNRC18 BRCA2 SUPT5H UNC79 RARG AHCTF1 PCLO PARP2 KAT6A NUMA1 CSF3R EGFR PHF3 PRKDC CDC25A SUFU ZMYM3 CFAP46

4.75e-0741921118int:HMGA1
InteractionCSNK2A1 interactions

ILF3 KDM5C CD2AP ECD NACA BCR BIRC6 PDCD4 TTBK2 STX1A DST PIK3C3 SUPT5H PRRC2C DDX24 SF3B2 WDR44 NAA15 ZCCHC8 WWP2 KAT6A ZFC3H1 PACS1 EGFR INF2 ASXL2 PRKDC MYB

8.61e-0795621128int:CSNK2A1
InteractionGUSBP5 interactions

HAUS6 KDM5C ZNF318 TNRC18 BRCA2 PIK3C2A HELZ ZFHX4

1.17e-06752118int:GUSBP5
InteractionEP300 interactions

TRERF1 ILF3 ABCF3 MAP4 NACA MAML1 BIRC6 PDCD4 BRCA2 SUPT5H G3BP2 TRMT1L TTC5 ALDOA DDX24 SF3B2 WDR44 NAA15 RARB RARG COPA RTN4 KAT6A NUMA1 CCNB1 SF3B3 EGFR SBNO1 PRPF3 NEMF PRKDC IL1B CDC25A EPAS1 MYB

1.35e-06140121135int:EP300
InteractionKIF20A interactions

ILF3 CHD2 ZNF318 CDK14 URB1 KIDINS220 PIK3C2A AHNAK G3BP2 SEC16A HELZ BOD1L1 ABCG2 UTRN SF3B2 RANBP2 COPA AHCTF1 PCLO NUMA1 HEATR1 KIAA1586 PPL SF3B3 GIGYF2 PRKDC CRYBG3 PARD3 SCIN

1.82e-06105221129int:KIF20A
InteractionGSK3A interactions

TRIO TEX2 MARK3 ECD BCR TNRC18 KIDINS220 DST SEC16A UTRN KIF26B ZDBF2 SF3B3 SBNO1 SIPA1L1 PRKDC CRYBG3 SUFU

2.04e-0646421118int:GSK3A
InteractionMAGEA9 interactions

HAUS6 NARS1 BRCA2 PIK3C2A TRMT1L TAF5 DDX24 ZDBF2 ZFC3H1 ZFHX4 SUGP1 PDCD11

2.09e-0620821112int:MAGEA9
InteractionCIT interactions

HAUS6 ILF3 NACA NARS1 CHD2 PARVB CMYA5 BIRC6 URB1 TRMT10C SUPT5H PRRC2C AHNAK G3BP2 BOD1L1 ABCG2 TRMT1L TAF5 SF3B2 RANBP2 COPA AHCTF1 PCLO NUMA1 HEATR1 C6orf132 MTMR4 SF3B3 INF2 PRPF3 PDCD11 PRKDC PATJ PARD3 CDC25A

2.92e-06145021135int:CIT
InteractionPTGES3 interactions

ERBB3 MARK3 CD2AP ECD NACA BCR BRCA2 PIK3C2A PIP5K1A TASOR RANBP2 TOPBP1 EGFR SBNO1 PDCD11 PRKDC PUS7L

3.82e-0643721117int:PTGES3
InteractionYAP1 interactions

TRERF1 MAP4 CD2AP ZNF318 TNRC18 PRRC2C AHNAK SEC16A BOD1L1 TAF5 ALDOA SF3B2 RARG COPA WWP2 AHCTF1 RTN4 NUMA1 HEATR1 JMJD1C SH3D21 SETD2 SF3B3 EGFR PHF3 GIGYF2 PRKDC PATJ PARD3

3.99e-06109521129int:YAP1
InteractionPOLR1G interactions

CHD2 URB1 SUPT5H TRMT1L DDX24 NAA15 ZCCHC8 KAT6A NUMA1 TOPBP1 HEATR1 ZFC3H1 SBNO1 PHF3 PDCD11 IKBKB CLSPN ZMYM3

4.25e-0648921118int:POLR1G
InteractionRPA4 interactions

HAUS6 MAP4 CD2AP NACA DST SUPT5H PRRC2C AHNAK SEC16A ALDOA SF3B2 RANBP2 AHCTF1 PARP2 NUMA1 SETD2 PARD3

5.98e-0645221117int:RPA4
InteractionCNOT9 interactions

HAUS6 ZNF318 BIRC6 PIK3C2A PRRC2C SEC16A HELZ JMJD1C EGFR ANKRD17 GIGYF2 MYB

6.15e-0623121112int:CNOT9
InteractionCDH1 interactions

ERBB3 PHACTR2 ABCF3 MAP4 MARK3 CD2AP KIDINS220 DST FMN1 AHNAK ALDOA UTRN NR0B2 COBLL1 RTN4 PPL C6orf132 CCNB1 EGFR GIGYF2 PRKDC PATJ PARD3

6.17e-0676821123int:CDH1
InteractionYWHAG interactions

PHACTR2 MARK3 CD2AP CDK14 BCR PDCD4 DST PIK3C2A PIK3C3 PRRC2C SEC16A HELZ BOD1L1 UTRN NAA15 KIF26B COBLL1 USP37 C6orf132 PACS1 MTMR4 SF3B3 PHF3 SIPA1L1 ANKRD17 GIGYF2 PRKDC PATJ PARD3 CDC25A ZMYM3

6.59e-06124821131int:YWHAG
InteractionBRCA1 interactions

ILF3 ZNF280D TRIO MAP4 NACA DST BRCA2 SUPT5H AHNAK SEC16A ALDOA DDX24 SF3B2 NAA15 ERO1B COPA ZCCHC8 SOX30 NUMA1 TOPBP1 USP37 AKAP12 CCNB1 GRPEL1 SF3B3 EGFR PRPF3 PRKDC IKBKB CLSPN ZMYM3

6.70e-06124921131int:BRCA1
InteractionBAP1 interactions

ILF3 MAP4 KDM5C CD2AP NACA NARS1 DST BRCA2 PRRC2C AHNAK G3BP2 SEC16A TRMT1L ALDOA SF3B2 RANBP2 NAA15 COPA AHCYL2 INO80 AKAP12 SF3B3 EGFR NEMF EIF4EBP3 ANKRD17 ASXL2 ELK3 PRKDC PATJ OGA MYB

6.90e-06131421132int:BAP1
InteractionRPS20 interactions

ILF3 ABCF3 MAP4 TNRC18 PRRC2C G3BP2 HELZ ALDOA NAA15 OXR1 WWP2 KAT6A NUMA1 TRIM31 EGFR ANKRD17 GIGYF2 MRPL1

8.20e-0651321118int:RPS20
InteractionH3C1 interactions

ZNF280D NACA PDCD4 TNRC18 PRRC2C AHNAK MLLT3 TAF5 DDX24 SF3B2 AHCTF1 COBLL1 PARP2 KAT6A NUMA1 JMJD1C GRPEL1 SETD2 EGFR XIRP2 CCNB3 PRPF3 PHF3 PRKDC MYB

8.94e-0690121125int:H3C1
InteractionDGKZ interactions

URB1 PIP5K1A TRMT1L DMD COX10 ZFC3H1 PDCD11 OGA

9.57e-06992118int:DGKZ
InteractionEXOSC3 interactions

G3BP2 MLLT3 DDX24 ZCCHC8 WWP2 KAT6A EGFR GIGYF2

1.03e-051002118int:EXOSC3
InteractionLRRC31 interactions

TRIO MAP4 PRRC2C AHNAK SEC16A COPA NUMA1 PARP14 EGFR ANKRD17 PRKDC

1.11e-0520521111int:LRRC31
InteractionSFN interactions

MAP4 TEX2 MARK3 CD2AP BCR DST PIK3C2A PRRC2C G3BP2 DDX24 KIF26B COBLL1 C6orf132 MTMR4 EGFR PHF3 SIPA1L1 ANKRD17 CRYBG3 PARD3 CDC25A

1.31e-0569221121int:SFN
InteractionSOX2 interactions

TRERF1 A2M SOX5 ILF3 MARK3 MAML1 TNRC18 KIDINS220 SUPT5H G3BP2 AKR1B10 SEC16A HELZ BOD1L1 TRMT1L DDX24 RANBP2 COPA ZCCHC8 WWP2 RTN4 NUMA1 ZDBF2 HEATR1 JMJD1C PPL SETD2 ZFHX4 EGFR SIPA1L1 PDCD11 ANKRD17 MRPL1

1.32e-05142221133int:SOX2
InteractionHDAC2 interactions

ILF3 ABCF3 TRIO MAP4 KDM5C NARS1 ZNF318 BRCA2 PRRC2C AHNAK G3BP2 DMD COPA WWP2 USP37 PARP14 JMJD1C INF2 SUGP1 ANKRD17 LTBP1 PRKDC EPAS1 ZMYM3

1.37e-0586521124int:HDAC2
InteractionACTC1 interactions

ERBB3 PHACTR2 CD2AP ZNF318 DST PDCL3 BOD1L1 DMD UTRN SF3B2 ZCCHC8 RNPC3 AHCTF1 COBLL1 NUMA1 SF3B3 INF2 PRPF3 PHF3 SUGP1 SCIN

1.37e-0569421121int:ACTC1
InteractionMEX3A interactions

TRIO KDM5C TNRC18 DST SACS PRRC2C AHNAK SEC16A COPA AHCTF1 KAT6A NUMA1 PARP14 PRKDC SCIN

1.37e-0538421115int:MEX3A
InteractionSNRPA interactions

ILF3 ZNF318 SUPT5H PRRC2C DDX24 TASOR SF3B2 ZCCHC8 TRIM31 ZFC3H1 SETD2 SF3B3 EGFR PRPF3 PHF3 SUGP1 PRKDC

1.38e-0548221117int:SNRPA
InteractionXRCC6 interactions

ILF3 MAP4 NARS1 ZNF318 TNRC18 BRCA2 SUPT5H BOD1L1 TRMT1L SF3B2 NAA15 AHCTF1 PARP2 NUMA1 TRIM31 JMJD1C CCNB1 EGFR PRPF3 PHF3 RNF146 SUGP1 ASXL2 PRKDC EPAS1

1.47e-0592821125int:XRCC6
InteractionYWHAQ interactions

PHACTR2 ILF3 ZNF280D MAP4 MARK3 CDK14 BCR MAP3K12 PDCD4 DST PIK3C2A PIK3C3 DDX24 UNC79 KIF26B WWP2 COBLL1 NUMA1 TRIM31 C6orf132 MTMR4 PPP2R5E EGFR SIPA1L1 ANKRD17 PRKDC PARD3 CDC25A

1.67e-05111821128int:YWHAQ
InteractionKDM1A interactions

TRERF1 HAUS6 ZNF280D CD2AP ZNF318 BCR BIRC6 DST BRCA2 SUPT5H AHNAK SEC16A TASOR UTRN SF3B2 RANBP2 ZCCHC8 ZDBF2 JMJD1C ZFHX4 ANKRD17 GIGYF2 CRYBG3 EPAS1 ZMYM3

1.86e-0594121125int:KDM1A
InteractionTERF1 interactions

MAP4 DST BRCA2 SUPT5H SEC16A DMD ALDOA DDX24 UTRN RTN4 KAT6A NUMA1 GRPEL1 PRKDC

1.87e-0534721114int:TERF1
InteractionEFTUD2 interactions

DDX59 ILF3 ABCF3 MAP4 ECD NACA NARS1 BIRC6 PDCD4 TRMT10C SUPT5H PRRC2C AHNAK G3BP2 TRMT1L ALDOA DDX24 SF3B2 RANBP2 NAA15 COPA WWP2 NUMA1 AHCYL2 USP37 SF3B3 EGFR SBNO1 PRPF3 NEMF GIGYF2 ASXL2 PRKDC

1.94e-05144921133int:EFTUD2
InteractionH2BC4 interactions

A2M MAP4 PDCD4 FSIP2 TNRC18 NAA15 AHCTF1 PARP2 NUMA1 JMJD1C SBNO1 PHF3

1.94e-0525921112int:H2BC4
InteractionNDN interactions

A2M ILF3 ECD SUPT5H PRRC2C AHNAK ALDOA DDX24 SF3B2 RANBP2 RTN4 NUMA1 SF3B3 EGFR GIGYF2 EPAS1

2.44e-0545321116int:NDN
InteractionPFN1 interactions

TRIO TEX2 BCR BIRC6 KIDINS220 PIK3C2A SEC16A BOD1L1 SF3B2 WDR44 RANBP2 COBLL1 PCLO C6orf132 INF2 CRYBG3 SCIN

2.76e-0550921117int:PFN1
InteractionMSH6 interactions

BIRC6 STX3 SUPT5H SF3B2 PARP2 TOPBP1 ZDBF2 MTMR4 SBNO1 ANKRD17 PRKDC CLSPN

3.03e-0527121112int:MSH6
InteractionZSCAN31 interactions

PIP5K1A TRMT1L MTMR4 PDCD11

3.19e-05182114int:ZSCAN31
InteractionSNRPB interactions

ILF3 ZNF318 SUPT5H TASOR SF3B2 COPA ZCCHC8 RNPC3 WWP2 RFX6 SETD2 SF3B3 EGFR PRPF3 PHF3 SUGP1 GIGYF2

3.36e-0551721117int:SNRPB
InteractionSLX4 interactions

NACA MAML1 ZNF318 BRCA2 SUPT5H ALDOA SF3B2 RANBP2 NUMA1 TOPBP1 ZFC3H1 SF3B3 SBNO1 PRPF3 SUGP1 PDCD11 PRKDC CLSPN

3.49e-0557221118int:SLX4
InteractionSIRT6 interactions

DDX59 ILF3 ABCF3 ZNF318 SUPT5H G3BP2 SEC16A TRMT1L NR0B2 RANBP2 PARP2 NUMA1 ZDBF2 ZFC3H1 SETD2 PRPF3 PHF3 ANKRD17 PRKDC

3.59e-0562821119int:SIRT6
InteractionMCAM interactions

ERBB3 MARK3 STX3 KIDINS220 DST FMN1 PIP5K1A DMD UTRN WDR44 FERMT3 KIF26B WWP2 DOCK10 AKAP12 PACS1

3.62e-0546821116int:MCAM
InteractionSSRP1 interactions

ILF3 CHD2 BRCA2 SUPT5H TASOR TXNDC2 RANBP2 ZCCHC8 WWP2 KAT6A GINS4 ZFC3H1 SETD2 EGFR SBNO1 PRPF3 PHF3 RNF146 PRKDC CLSPN

3.67e-0568521120int:SSRP1
InteractionHECTD1 interactions

MAP4 MARK3 NACA BIRC6 PDCD4 URB1 PIK3C3 PRRC2C G3BP2 TRMT1L DDX24 TASOR UTRN COPA RNPC3 KAT6A NUMA1 TOPBP1 HEATR1 ZFC3H1 PRPF3 PHF3 NEMF PDCD11 PRKDC

3.89e-0598421125int:HECTD1
InteractionCDC25C interactions

ERBB3 MARK3 CCNB1 GRPEL1 EGFR SIPA1L1 GIGYF2 CDC25A SUFU

4.03e-051562119int:CDC25C
InteractionWWTR1 interactions

HAUS6 CD2AP ZNF318 PRRC2C SEC16A WDR44 AHCTF1 NUMA1 HEATR1 JMJD1C SETD2 PHF3 PDCD11 PATJ PARD3

4.10e-0542221115int:WWTR1
InteractionFBXW11 interactions

ILF3 NACA PDCD4 PIK3C2A PDCL3 HELZ SF3B2 RANBP2 AHCYL2 USP37 PPP2R5E EGFR SIPA1L1 IKBKB CLSPN CDC25A

4.10e-0547321116int:FBXW11
InteractionRNF2 interactions

ILF3 ABCF3 KDM5C PIK3C3 SUPT5H G3BP2 SEC16A HELZ MLLT3 DDX24 TASOR SF3B2 RANBP2 COPA ZCCHC8 RNPC3 WWP2 PCLO NUMA1 HEATR1 SF3B3 PDCD11 ZMYM3

4.13e-0586621123int:RNF2
InteractionDOT1L interactions

ILF3 URB1 SUPT5H G3BP2 MLLT3 TRMT1L DDX24 TASOR SF3B2 RANBP2 ZCCHC8 AHCTF1 HEATR1 INO80 ZFC3H1 SF3B3 PRPF3 PHF3 PDCD11 GIGYF2 PRKDC ZMYM3

4.16e-0580721122int:DOT1L
InteractionPTEN interactions

ERBB3 ILF3 NACA ZNF318 BIRC6 RYR3 FSIP2 TTBK2 G3BP2 METTL16 DDX24 UTRN RANBP2 COPA WWP2 PPL AKAP12 SF3B3 EGFR INF2 RNF146 PDCD11 PRKDC SUFU

4.32e-0592921124int:PTEN
InteractionRNF43 interactions

HAUS6 ILF3 ZNF318 KIDINS220 SEC16A HELZ UTRN RANBP2 AHCTF1 JMJD1C PPL C6orf132 GIGYF2 CRYBG3 PARD3

4.68e-0542721115int:RNF43
InteractionYWHAZ interactions

ERBB3 TEX2 MARK3 CDK14 BCR FSIP2 DST PIK3C2A PIK3C3 KCTD16 ALDOA DDX24 SF3B2 KIF26B WWP2 COBLL1 KAT6A GINS4 C6orf132 PACS1 MTMR4 EGFR PHF3 SIPA1L1 ANKRD17 GIGYF2 ASXL2 PARD3 IL1B CDC25A

4.97e-05131921130int:YWHAZ
InteractionNANOG interactions

TRERF1 ERBB3 ILF3 PRAM1 BRCA2 G3BP2 SEC16A PCDH15 DDX24 RANBP2 PDPR ZCCHC8 AHCTF1 JMJD1C PPP2R5E SUGP1

5.01e-0548121116int:NANOG
InteractionSUZ12 interactions

ILF3 CHD2 BIRC6 G3BP2 TRMT1L ALDOA TASOR SF3B2 RANBP2 RARG COPA AHCTF1 NUMA1 HEATR1 PARP14 SF3B3 PDCD11 ASXL2 IL1B

5.04e-0564421119int:SUZ12
InteractionHNRNPA1 interactions

ILF3 PDCD4 G3BP2 AKR1B10 SEC16A DNAJC12 ALDOA DDX24 TASOR NR0B2 SF3B2 WWP2 NUMA1 TRIM31 PPL ZNF35 EGFR PRPF3 PHF3 PDCD11 ASXL2 PRKDC SUFU MRPL1

5.65e-0594521124int:HNRNPA1
InteractionTERF2 interactions

MARK3 DST BRCA2 SUPT5H G3BP2 SEC16A DMD DDX24 UTRN SF3B2 KAT6A NUMA1 EGFR

6.46e-0534021113int:TERF2
InteractionIFI16 interactions

ILF3 NARS1 URB1 SUPT5H G3BP2 HELZ TRMT1L DDX24 TASOR COPA AHCTF1 NUMA1 HEATR1 FCF1 SF3B3 EGFR INF2 PRPF3 NEMF PDCD11

6.52e-0571421120int:IFI16
InteractionSNRPC interactions

ILF3 ZNF318 SUPT5H TASOR SF3B2 ZCCHC8 WWP2 RFX6 SETD2 SF3B3 EGFR PRPF3 PHF3 SUGP1 GIGYF2

6.57e-0544021115int:SNRPC
InteractionTNS1 interactions

ERBB3 CTNNAL1 DMD UTRN EGFR

6.62e-05412115int:TNS1
InteractionDHX40 interactions

ZNF318 URB1 SUPT5H TASOR ZCCHC8 ZDBF2 ZFC3H1 SETD2 MTMR4 PDCD11 CLSPN

6.65e-0524921111int:DHX40
InteractionVASP interactions

BCR SEC16A SF3B2 WWP2 COBLL1 C6orf132 EGFR XIRP2 INF2 SIPA1L1 PATJ PARD3

6.67e-0529421112int:VASP
InteractionGRWD1 interactions

ILF3 NACA URB1 PDCL3 DDX24 SF3B2 COPA WWP2 KAT6A TRIM31 CCNB1 SF3B3 PDCD11 PRKDC

6.67e-0539021114int:GRWD1
InteractionPRPF8 interactions

ILF3 MAP4 ECD NACA SUPT5H AHNAK G3BP2 SEC16A BOD1L1 ALDOA SF3B2 FKBP15 RANBP2 WWP2 KAT6A TRIM31 SF3B3 EGFR PRPF3 GIGYF2 PRKDC

6.96e-0577621121int:PRPF8
InteractionLYN interactions

ERBB3 CTNNAL1 TRIO MARK3 PRAM1 KIDINS220 DST PIP5K1A DMD UTRN PRUNE2 KIF26B COBLL1 AKAP12 PACS1 CSF3R EGFR PRKDC PARD3 IL1B

7.31e-0572021120int:LYN
InteractionDCPS interactions

URB1 AHNAK SF3B2 FERMT3 RANBP2 COPA AHCTF1 GINS4 PARP14 C6orf132 SF3B3 PHF3 PDCD11 PRKDC

7.44e-0539421114int:DCPS
InteractionRHOB interactions

PHACTR2 TRIO MARK3 BCR TRMT10C STX3 KIDINS220 PIP5K1A DDX24 UTRN SDC2 WDR44 KIF26B WWP2 AHCYL2 AKAP12 CCNB1 EGFR SIPA1L1 NCOA7 PATJ PARD3

7.51e-0584021122int:RHOB
InteractionOBSL1 interactions

ILF3 URB1 DST SUPT5H AHNAK G3BP2 TRMT1L ALDOA UTRN SF3B2 PRUNE2 RANBP2 COPA PCLO NUMA1 HEATR1 MTMR4 SF3B3 PRPF3 NEMF PDCD11 PRKDC SCIN

7.66e-0590221123int:OBSL1
InteractionZFPL1 interactions

CTNNAL1 TRIO MARK3 STX1A KIDINS220 DST PIK3C3 SEC16A UTRN COPA AKAP12 MTMR4 PPP2R5E EGFR PARD3

8.03e-0544821115int:ZFPL1
InteractionEGLN3 interactions

HAUS6 ECD MAML1 ZNF318 CDK14 BCR BIRC6 TRMT10C KIDINS220 BRCA2 PIK3C2A SEC16A HELZ UTRN RANBP2 PDPR COPA TOPBP1 JMJD1C PHF3 ANKRD17 GIGYF2 PRKDC IKBKB CLSPN PARD3 CDC25A SUFU EPAS1

8.95e-05129621129int:EGLN3
InteractionWDR5 interactions

ILF3 MAP4 NACA NARS1 PRRC2C G3BP2 BOD1L1 METTL16 UTRN SF3B2 RANBP2 NAA15 COPA WWP2 AHCTF1 KAT6A HEATR1 INO80 PARP14 PDCD11 GIGYF2 ASXL2 PRKDC CLSPN EPAS1 MYB

9.05e-05110121126int:WDR5
InteractionH2AC4 interactions

CD2AP CHD2 SUPT5H PIP5K1A DDX24 UNC79 SF3B2 DNAH10 PARP2 NUMA1 INO80 PRPF3 PDCD11 PRKDC ZMYM3 MYB

9.07e-0550621116int:H2AC4
InteractionPLK1 interactions

BCR BIRC6 BRCA2 SACS RANBP2 TOPBP1 USP37 AKAP12 CCNB1 MTMR4 SF3B3 EGFR PRKDC IKBKB CLSPN PARD3

9.94e-0551021116int:PLK1
InteractionAKR7L interactions

MARK3 DST NEMF PDCD11 GIGYF2 PARD3

1.08e-04722116int:AKR7L
InteractionCDK9 interactions

ILF3 MAP4 BRCA2 SUPT5H PRRC2C G3BP2 AKR1B10 NGEF MLLT3 DDX24 SF3B2 WWP2 NUMA1 EGFR SIPA1L1 PDCD11 PRKDC CLSPN IL1B

1.13e-0468521119int:CDK9
InteractionHDAC4 interactions

ILF3 TRIO TEX2 MARK3 NARS1 PDCD4 FMN1 PRRC2C NGEF TRMT1L RANBP2 NAA15 COPA ACAD10 INO80 ACTR3B SIPA1L1 NEMF GIGYF2 PARD3

1.14e-0474421120int:HDAC4
InteractionDUT interactions

BIRC6 BOD1L1 ALDOA SELENBP1 COPA GRPEL1 EGFR ASXL2

1.16e-041402118int:DUT
InteractionSF3B2 interactions

PRRC2C DMD SF3B2 RANBP2 COPA ZCCHC8 RNPC3 WWP2 TOPBP1 SF3B3 EGFR PRPF3 SUGP1 GIGYF2 ASXL2 PRKDC

1.16e-0451721116int:SF3B2
InteractionPARP1 interactions

ILF3 MARK3 ECD NARS1 URB1 KIDINS220 BRCA2 SACS SUPT5H PIP5K1A TRMT1L NAA15 RARB WWP2 PARP2 NUMA1 TOPBP1 ACAD10 HEATR1 CCNB1 EGFR PHF3 RNF146 PDCD11 ASXL2 PRKDC CLSPN ZMYM3 MYB

1.17e-04131621129int:PARP1
InteractionPML interactions

ILF3 ABCF3 MAP4 CD2AP ZNF318 AHNAK SEC16A ALDOA RANBP2 RTN4 KAT6A NUMA1 TOPBP1 HEATR1 PARP14 JMJD1C EGFR SBNO1 PRPF3 PHF3 SUGP1 ZMYM3 MYB

1.27e-0493321123int:PML
InteractionSF3B5 interactions

ILF3 SUPT7L NGEF SF3B2 WWP2 USP37 SF3B3 EGFR

1.34e-041432118int:SF3B5
InteractionSSH3 interactions

KDM5C BIRC6 NUMA1 SF3B3 INF2 CRYBG3

1.46e-04762116int:SSH3
InteractionAXL interactions

ERBB3 TRMT10C KIDINS220 AHNAK G3BP2 UTRN AHCTF1 RTN4 AHCYL2 AKAP12 CSF3R EGFR PRKDC

1.46e-0436921113int:AXL
GeneFamilyDyneins, axonemal

DNAH14 DNAH10 DNAH17

2.79e-04171393536
GeneFamilyErb-b2 receptor tyrosine kinases

ERBB3 EGFR

3.49e-04413921096
GeneFamilyEF-hand domain containing|Plakins

DST PPL

1.59e-0381392939
GeneFamilyPhosphatidylinositol 3-kinase subunits

PIK3C2A PIK3C3

1.59e-0381392831
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

TRIO MARK3 CD2AP KIDINS220 DST BRCA2 PIK3C2A SACS PIK3C3 PRRC2C PIP5K1A HELZ DMD TASOR RANBP2 AHCTF1 KAT6A TOPBP1 SETD2 PPP2R5E EGFR PHF3 SIPA1L1 ANKRD17 GIGYF2 CRYBG3 PARD3

1.56e-0985621127M4500
CoexpressionBUSSLINGER_GASTRIC_IMMUNE_CELLS

TRERF1 HAUS6 MARK3 CHD2 DENND2D IL18RAP BIRC6 PDCD4 KIDINS220 SACS AHNAK G3BP2 HELZ BOD1L1 DDX24 TASOR UTRN TBCC FERMT3 RANBP2 KAT6A NUMA1 DOCK10 ZFC3H1 PARP14 JMJD1C HIVEP3 PACS1 SETD2 PPP2R5E SF3B3 SBNO1 PHF3 NEMF ASXL2 OGA

3.31e-09149221136M40023
CoexpressionNAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN

KDM5C CHD2 BCR PDCD4 PIK3C2A BOD1L1 METTL16 DDX24 RANBP2 ERO1B WWP2 AHCTF1 RTN4 KAT6A ZDBF2 ZFC3H1 JMJD1C PRPF3 PHF3 SIPA1L1 GIGYF2 OGA

3.64e-0868021122M41089
CoexpressionMURARO_PANCREAS_BETA_CELL

PHACTR2 PARVB ZNF318 STX1A STX3 KIDINS220 DST PIK3C2A G3BP2 DNAJC12 DDX24 UNC79 UTRN TBCC PRUNE2 RANBP2 ERO1B AHCTF1 COBLL1 PCLO RTN4 DOCK10 PPL SBNO1 GIGYF2 LONRF2

5.19e-0894621126M39169
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN

TRIO MARK3 CD2AP DST PIK3C3 PRRC2C HELZ TASOR KAT6A TOPBP1 SETD2 PPP2R5E EGFR PHF3 ANKRD17 GIGYF2 PARD3

2.66e-0746621117M13522
CoexpressionLAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2

TRIO CDK14 DNAH14 PRUNE2 OXR1 AKAP12 SIPA1L1 PATJ PARD3 L3MBTL4

1.75e-0617621110M39223
CoexpressionLAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2

CDK14 PRRC2C PCDH15 PRUNE2 PCLO SIPA1L1 PATJ PARD3 OGA L3MBTL4

1.32e-0522121110M39222
CoexpressionGSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP

HAUS6 CTNNAL1 BCR FERMT3 ERO1B USP37 ZFHX4 IKBKB RAI2

3.07e-051952119M3098
CoexpressionGSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_UP

CD2AP ZNF318 TMEM186 COX10 RFX6 INO80 OVGP1 EPAS1

3.36e-051522118M343
CoexpressionLAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR

A2M SOX5 DST PIK3C2A AHNAK UTRN CRYBG3 EPAS1

3.36e-051522118M39243
CoexpressionDAZARD_RESPONSE_TO_UV_NHEK_DN

ERBB3 MAML1 ZNF318 DST SACS PIK3C3 HELZ KAT6A ZFC3H1 CCNB1 PHF3

3.45e-0530021111M8702
CoexpressionGSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP

ILF3 DENND2D AKR1B10 MLLT3 DMD RARG TOPBP1 SF3B3 SUGP1

3.46e-051982119M7046
CoexpressionGSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP

DDX59 CTNNAL1 CHD2 STX1A ERO1B OVGP1 PARD3 MRPL1 ZMYM3

3.59e-051992119M9320
CoexpressionGSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN

CHD2 DENND2D PDCD4 STX1A HELZ DDX24 RARG OXR1 AKAP12

3.74e-052002119M7186
CoexpressionGSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP

MAML1 IL18RAP KIDINS220 PIK3C2A UTRN OXR1 AHCYL2 PARP14 RNF146

3.74e-052002119M6253
CoexpressionGSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP

HAUS6 ZNF280D TRMT10C TRMT1L SF3B2 WDR44 ERO1B OVGP1 CDC25A

3.74e-052002119M5613
CoexpressionIBRAHIM_NRF1_UP

MAP4 MARK3 NACA NARS1 RYR3 KIDINS220 AKR1B10 ALDOA RTN4 AHCYL2 GRPEL1 PPP2R5E SBNO1

3.94e-0542021113M42509
CoexpressionGSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_UP

KIDINS220 SEC16A FKBP15 RARG DOCK10 PARP14 IFNGR2 WEE2

4.84e-051602118M7116
CoexpressionSENESE_HDAC3_TARGETS_UP

TRIO STX1A DST G3BP2 AKR1B10 PIP5K1A METTL16 RANBP2 COPA AHCTF1 KAT6A HEATR1 JMJD1C ELK3

5.29e-0549521114M8451
CoexpressionBONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING

PHACTR2 CDK14 DST G3BP2 ABCG2 SDC2 LRRC8E RANBP2 RARB RARG SETD2 SUGP1 IKBKB PATJ

6.69e-0550621114M253
CoexpressionGSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN

TRERF1 CD2AP PIK3C2A JMJD1C IFNGR2 SIPA1L1 PATJ MYB

7.73e-051712118M6321
CoexpressionDE_YY1_TARGETS_DN

CD2AP DST NAA15 NUMA1 EGFR EPAS1

1.08e-04932116M3278
CoexpressionGSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP

BIRC6 PRRC2C UTRN USP37 SETD2 SBNO1 SIPA1L1 SUFU

1.10e-041802118M8239
CoexpressionGSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_DN

TEX2 IL18RAP TTBK2 DST AHNAK DNAJC12 COBLL1 AKAP12

1.15e-041812118M8889
CoexpressionFISCHER_DREAM_TARGETS

HAUS6 ILF3 BIRC6 BRCA2 METTL16 TAF5 NAA15 RNPC3 AHCTF1 PARP2 TOPBP1 GINS4 HEATR1 USP37 CCNB1 SF3B3 ANKRD17 PRKDC CLSPN CDC25A

1.19e-0496921120M149
CoexpressionGSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP

CHD2 SEC16A MLLT3 UTRN ACAD10 PARP14 SBNO1 MYB

1.29e-041842118M9005
CoexpressionAIZARANI_LIVER_C39_EPCAM_POS_BILE_DUCT_CELLS_4

MAP4 DST AHNAK RTN4 C6orf132 IFNGR2 EGFR NCOA7

1.29e-041842118M39135
CoexpressionPATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_UP

PHACTR2 SLC41A2 PRRC2C G3BP2 AKAP12 IFNGR2 SIPA1L1 NCOA7 IL1B MYB

1.34e-0429121110M41002
CoexpressionPILON_KLF1_TARGETS_UP

A2M CTNNAL1 TRIO AKR1B10 MLLT3 ABCG2 SDC2 KIF26B SBNO1 AKR1B15 GIGYF2 ASXL2 IL1B OGA

1.35e-0454121114MM1061
CoexpressionNAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP

ILF3 TRIO MAP4 ZNF318 BRCA2 PIK3C3 PDCL3 PIP5K1A TBCC PARP2 FCF1 PPP2R5E SUGP1

1.36e-0447521113M40979
CoexpressionMARTINEZ_RB1_AND_TP53_TARGETS_DN

SOX5 CTNNAL1 ILF3 ZNF280D MAP4 MAML1 BCR DMD SF3B2 RARG NUMA1 C6orf132 EGFR LTBP1 SDHAF4

1.37e-0461021115M3854
CoexpressionLEE_BMP2_TARGETS_DN

HAUS6 NARS1 SLC41A2 URB1 TRMT10C SACS NGEF MLLT3 METTL16 TAF5 NAA15 TOPBP1 COX10 HEATR1 SF3B3 PDCD11 CLSPN CDC25A PUS7L

1.40e-0490421119M2325
CoexpressionMARTINEZ_TP53_TARGETS_DN

SOX5 CTNNAL1 ILF3 ZNF280D MAP4 MAML1 BCR DMD SF3B2 RARG NUMA1 C6orf132 EGFR SDHAF4 EPAS1

1.49e-0461521115M8673
CoexpressionLAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM

CHD2 FMN1 PRRC2C PCDH15 PIP5K1A DMD PRUNE2 KIF26B ZFC3H1 PPP2R5E OGA CFAP46

1.55e-0441721112M39224
CoexpressionPGF_UP.V1_UP

CD2AP SACS TASOR RARB AHCYL2 PHF3 LTBP1 CRYBG3

1.60e-041902118M2674
CoexpressionLEE_BMP2_TARGETS_DN

HAUS6 NARS1 SLC41A2 URB1 TRMT10C SACS NGEF MLLT3 METTL16 TAF5 NAA15 TOPBP1 COX10 HEATR1 SF3B3 PDCD11 CLSPN CDC25A PUS7L

1.80e-0492221119MM1068
CoexpressionGSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP

ILF3 CHD2 PRRC2C DDX24 RANBP2 JMJD1C PHF3 GIGYF2

1.98e-041962118M4928
CoexpressionGSE360_CTRL_VS_T_GONDII_MAC_DN

KDM5C BRCA2 UTRN NR0B2 SDC2 COX10 IFNGR2 PRPF3

2.12e-041982118M5163
CoexpressionGSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP

CD2AP STX1A PIK3C2A HEATR1 RNF146 IKBKB PATJ MYB

2.12e-041982118M9035
CoexpressionGSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_DN

ZNF280D ECD RYR3 ZCCHC8 WWP2 DOCK10 SBNO1 MYB

2.20e-041992118M8259
CoexpressionGSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN

NOG ABCF3 ZNF280D RNPC3 KAT6A ACAD10 OVGP1 PATJ

2.20e-041992118M8606
CoexpressionGSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP

ILF3 CHD2 TTC5 PLXNA3 COPA RTN4 OVGP1 SF3B3

2.20e-041992118M7325
CoexpressionGSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP

CTNNAL1 MAP4 ABCG2 UTRN ZDBF2 AKAP12 ZFHX4 SCIN

2.20e-041992118M7766
CoexpressionGSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP

ILF3 RYR3 TTBK2 PIK3C2A SUPT5H SUGP1 ANKRD17 PRKDC

2.20e-041992118M6839
CoexpressionGSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN

TRIO CATSPER3 ZNF318 PRAM1 ABCG2 ERO1B COX10 PUS7L

2.20e-041992118M9159
CoexpressionGSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP

HAUS6 TRMT1L WDR44 AHCTF1 TOPBP1 JMJD1C OVGP1 CDC25A

2.20e-041992118M5607
CoexpressionGSE27786_LSK_VS_NKCELL_DN

MARK3 CD2AP PDCD4 KIDINS220 ERO1B AKAP12 EGFR SBNO1

2.27e-042002118M4753
CoexpressionGSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN

URB1 KIDINS220 AHNAK DNAJC12 GINS4 WEE2 MRPL1 MYB

2.27e-042002118M7356
CoexpressionGSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN

MLLT3 TAF5 DOCK10 PARP14 JMJD1C HIVEP3 OGA EPAS1

2.27e-042002118M6247
CoexpressionGSE7852_LN_VS_FAT_TREG_UP

HAUS6 STX1A TRMT1L TOPBP1 MTMR4 OVGP1 SUGP1 PATJ

2.27e-042002118M5739
CoexpressionGSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_DN

TTBK2 TTC5 NR0B2 RARG ACTR3B PPL LRRC3B MYB

2.27e-042002118M4314
CoexpressionGSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN

HAUS6 RBM44 SACS UBD HIVEP3 PPP2R5E ASXL2 LONRF2

2.27e-042002118M6966
CoexpressionKRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP

PHACTR2 DDX59 ILF3 CHD2 PARVB IL18RAP PDCD4 TTBK2 URB1 PRRC2C DNAJC12 UTRN NAA15 ZCCHC8 ACTR3B USP37 RNF146 PDCD11 OGA

2.36e-0494221119M8144
CoexpressionPILON_KLF1_TARGETS_UP

A2M CTNNAL1 TRIO AKR1B10 MLLT3 ABCG2 SDC2 KIF26B SBNO1 GIGYF2 ASXL2 IL1B OGA

2.37e-0450321113M2226
CoexpressionLAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES

A2M SOX5 DST DMD UTRN AKAP12 EPAS1

2.70e-041552117M39246
CoexpressionMARTINEZ_RB1_AND_TP53_TARGETS_DN

SOX5 CTNNAL1 ILF3 ZNF280D MAP4 MAML1 BCR DMD SF3B2 RARG NUMA1 C6orf132 EGFR LTBP1 SDHAF4

2.70e-0465021115MM1042
CoexpressionGSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN

CD2AP PARVB PRRC2C SUPT7L INSYN2B ASXL2 PRKDC

2.92e-041572117M7733
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

HAUS6 CTNNAL1 NARS1 TRMT10C KIDINS220 SACS TASOR NAA15 AHCTF1 DOCK10 ZNF407 PHF3 NEMF EIF4EBP3 PUS7L

2.98e-0465621115M18979
CoexpressionZHANG_BREAST_CANCER_PROGENITORS_UP

ILF3 ACTR3C CD2AP G3BP2 MLLT3 ZCCHC8 TOPBP1 ACTR3B SBNO1 CDC25A PUS7L MYB

2.98e-0444821112MM1044
CoexpressionMARTINEZ_TP53_TARGETS_DN

SOX5 CTNNAL1 ILF3 ZNF280D MAP4 MAML1 BCR DMD SF3B2 RARG NUMA1 C6orf132 EGFR SDHAF4 EPAS1

3.12e-0465921115MM1040
CoexpressionSENESE_HDAC1_TARGETS_UP

PHACTR2 TRIO STX3 PIK3C2A G3BP2 PIP5K1A FKBP15 COPA AHCTF1 COBLL1 DOCK10 ELK3

3.17e-0445121112M14973
CoexpressionHAN_SATB1_TARGETS_DN

TRERF1 ERBB3 DST DNAJC12 RARG SELENBP1 ZCCHC8 KAT6A EGFR SBNO1 IL1B

3.30e-0438821111M15491
CoexpressionHE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL

STX1A DST DNAJC12 UNC79 PRUNE2 PCLO RFX6 HIVEP3 LONRF2

3.42e-042682119M45696
CoexpressionMARTINEZ_RESPONSE_TO_TRABECTEDIN_DN

BIRC6 SACS SEC16A FKBP15 JMJD1C MTMR4 PPP2R5E EGFR MRPL1

3.80e-042722119M15123
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000

SOX5 RBM44 MAP4 ZNF318 SLC41A2 STX3 SACS WDR44 PPP2R5E CCNB3 GIGYF2 INSYN2B ASXL2 LONRF2

7.12e-0823020914gudmap_developingGonad_e18.5_ovary_1000_k5
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000

SOX5 RBM44 MAP4 CD2AP CHD2 ZNF318 BIRC6 BRCA2 SACS PIP5K1A UTRN WDR44 PDPR NAA15 COPA RNPC3 AHCYL2 JMJD1C PPP2R5E SBNO1 CCNB3 ANKRD17 GIGYF2 INSYN2B ASXL2

2.03e-0777620925gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000

SOX5 RBM44 MAP4 CHD2 ZNF318 BIRC6 SLC41A2 STX3 SACS PRRC2C G3BP2 UTRN WDR44 PDPR NAA15 ERO1B COPA AHCYL2 PPP2R5E SBNO1 CCNB3 GIGYF2 INSYN2B ASXL2 LONRF2

2.13e-0777820925gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlasDevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000

SOX5 RBM44 MAP4 CHD2 ZNF318 BIRC6 SLC41A2 STX3 SACS PRRC2C G3BP2 PIP5K1A UTRN WDR44 PDPR NAA15 ERO1B COPA AHCYL2 SBNO1 CCNB3 ANKRD17 GIGYF2 INSYN2B LONRF2

3.19e-0779520925gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3

HAUS6 BIRC6 BRCA2 PRRC2C MLLT3 TRMT1L WDR44 RANBP2 AHCTF1 PCLO RTN4 ZDBF2 USP37 CCNB1 PHF3 NEMF GIGYF2 PRKDC CLSPN

1.44e-0653220919Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000

ERBB3 PHACTR2 ILF3 TRIO KDM5C BIRC6 RYR3 DST PIK3C2A ATP2C2 MLLT3 FERMT3 RARB KIF26B WWP2 INO80 ZFHX4 EGFR PHF3 SIPA1L1 GIGYF2 ASXL2 ELK3 PATJ

1.46e-0680620924gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlasFacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2

HAUS6 ZNF280D TRIO MARK3 NARS1 CHD2 MAP3K12 TASOR UTRN RNPC3 KAT6A TOPBP1 ZNF407 HEATR1 INO80 JMJD1C ANKRD17 ASXL2 OGA

3.38e-0656420919Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000

SOX5 RBM44 ZNF280D MAP4 CD2AP CHD2 BIRC6 PRRC2C G3BP2 PIP5K1A UTRN NAA15 COPA AHCYL2 JMJD1C IFNGR2 PPP2R5E ZFHX4 ANKRD17 GIGYF2 INSYN2B ASXL2 CDC25A

4.77e-0680420923gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlasDevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000

ERBB3 PHACTR2 ILF3 CD2AP BIRC6 STX1A STX3 PIK3C2A PRRC2C AKR1B10 HELZ UTRN ERO1B KIF26B WWP2 AHCTF1 INO80 C6orf132 SBNO1 ASXL2 PATJ SCIN

1.09e-0578620922gudmap_developingKidney_e15.5_Medullary collecting duct_1000
CoexpressionAtlasDevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000

PHACTR2 ILF3 CD2AP BIRC6 STX1A PIK3C2A PRRC2C UTRN ERO1B INO80 SBNO1 ASXL2

1.14e-0526120912gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4
CoexpressionAtlasDevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000

SOX5 RBM44 ZNF318 SLC41A2 STX3 SACS WDR44 CCNB3 GIGYF2 INSYN2B LONRF2

1.17e-0521920911gudmap_developingGonad_e16.5_ovary_1000_k5
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4

ZNF280D TRIO CHD2 MAP3K12 PDCL3 HELZ BOD1L1 TASOR PDPR PCLO PARP2 KAT6A ZNF407 ZDBF2 SIPA1L1 ASXL2 CLSPN OGA

2.62e-0559520918Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlasdev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000

SOX5 CTNNAL1 CD2AP PARVB PDCD4 SLC41A2 TNRC18 DST PIK3C2A AHNAK AKR1B10 PIP5K1A TXNDC2 SELENBP1 SH3D21 IFNGR2 ZFHX4 NCOA7 INSYN2B PATJ ZMYM3

3.79e-0579120921gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500

HAUS6 TTBK2 MLLT3 KIF26B ZFHX4 EGFR GIGYF2 LTBP1 ASXL2 RAI2 MYB

3.83e-0524920911gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000

SOX5 RBM44 MAP4 CD2AP CHD2 ZNF318 BIRC6 TNRC18 PRRC2C G3BP2 PIP5K1A UTRN PDPR NAA15 COPA AHCYL2 PPP2R5E SBNO1 AKR1B15 ANKRD17 CDC25A

4.97e-0580620921gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlasFacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1

DST PIK3C2A PRRC2C TRMT1L WDR44 PCLO ZDBF2 PHF3 NEMF GIGYF2 PRKDC

5.48e-0525920911Facebase_RNAseq_e8.5_Floor Plate_1000_K1
CoexpressionAtlasDevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_1000

ERBB3 CTNNAL1 ILF3 CD2AP DENND2D MAP3K12 STX1A STX3 DST PIK3C2A ATP2C2 UTRN LRRC8E KIF26B PPL C6orf132 GIGYF2 ASXL2 PATJ SCIN

1.01e-0478420920gudmap_developingLowerUrinaryTract_e15.5_urothelium_1000
CoexpressionAtlasdev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000

CTNNAL1 PARVB CDK14 PDCD4 SLC41A2 TNRC18 DST PIK3C2A AHNAK AKR1B10 MLLT3 TXNDC2 UTRN SDC2 SH3D21 IFNGR2 ZFHX4 LRRC3B INSYN2B ZMYM3

1.39e-0480320920gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000
CoexpressionAtlasdev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000

RBM44 TEX2 ZNF318 PDCD4 URB1 BRCA2 HELZ HFM1 TAF5 WDR44 PDPR HEATR1 ACTR3B USP37 SF3B3 PRPF3 SUGP1 PRKDC CLSPN LONRF2

1.83e-0482020920gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlasdev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000

SOX5 CTNNAL1 CD2AP PARVB SLC41A2 TNRC18 DST PIK3C2A SUPT5H G3BP2 AKR1B10 TXNDC2 UTRN SELENBP1 DOCK10 IFNGR2 ZFHX4 NCOA7 PATJ ZMYM3

2.39e-0483720920gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500

HAUS6 TTBK2 DST MLLT3 KIF26B ZFHX4 EGFR GIGYF2 INSYN2B LTBP1 ASXL2 RAI2 MYB

3.40e-0442820913gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500
CoexpressionAtlasDevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000

ILF3 BIRC6 STX1A STX3 DST PIK3C2A PRRC2C UTRN SF3B2 WWP2 COBLL1 INO80 PHF3 NCOA7 GIGYF2 ASXL2 PATJ SCIN MYB

3.43e-0479520919gudmap_developingKidney_e15.5_anlage of loop of Henle_1000
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_500

RBM44 ZNF318 BIRC6 WDR44 CCNB3 GIGYF2 INSYN2B

3.70e-041342097gudmap_developingGonad_e18.5_ovary_500_k1
CoexpressionAtlasDevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000

ERBB3 ILF3 TRIO CD2AP BIRC6 STX1A STX3 PIK3C2A PRRC2C NAA15 AHCTF1 COBLL1 INO80 C6orf132 GIGYF2 ASXL2 PATJ SCIN MYB

3.76e-0480120919gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000

ILF3 TRIO MAP4 RYR3 DST PIK3C2A MLLT3 SF3B2 RARB ERO1B KIF26B INO80 ZFHX4 EGFR PHF3 GIGYF2 INSYN2B ASXL2 OGA

4.06e-0480620919DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000

RBM44 ZNF318 PDPR RNPC3 PPP2R5E CCNB3 INSYN2B ASXL2

4.08e-041792098gudmap_developingGonad_e14.5_ ovary_1000_k5
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000

MAP4 KDM5C CHD2 G3BP2 PIP5K1A UTRN COPA AHCYL2 JMJD1C GIGYF2

4.15e-0427520910gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlasdev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000

RBM44 TEX2 ZNF318 PDCD4 URB1 BRCA2 FMN1 HFM1 METTL16 TAF5 HEATR1 ACTR3B CCNB1 SF3B3 SBNO1 PRPF3 PDCD11 PRKDC CLSPN

4.31e-0481020919gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CHD2 BIRC6 PRRC2C AHNAK HELZ BOD1L1 DDX24 UTRN ZFC3H1 PARP14 JMJD1C SETD2 PHF3

1.59e-112002121312f1685ce8f218433068e090c9d839cd5a1910bf
ToppCelldroplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2AP BIRC6 PRRC2C AHNAK TASOR UTRN KAT6A DOCK10 JMJD1C AKAP12 SETD2 PHF3

9.39e-11184212121154a5ad7b8512272b7476f949ddac350910bfb7
ToppCellmild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

A2M PHACTR2 CD2AP IL18RAP PDCD4 HELZ ABCG2 DDX24 UTRN ZDBF2 PHF3 ELK3

2.33e-1019921212cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

CD2AP BIRC6 PIK3C2A UTRN RANBP2 USP37 GIGYF2 ASXL2 PRKDC CRYBG3 PUS7L

2.40e-0919321211abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells)

DST SUPT5H ATP2C2 PARP2 ZNF407 KIAA1586 PARP14 EIF4EBP3 PDCD11 PATJ SDHAF4

2.54e-091942121188db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells)

DST SUPT5H ATP2C2 PARP2 ZNF407 KIAA1586 PARP14 EIF4EBP3 PDCD11 PATJ SDHAF4

2.54e-0919421211a71728202493d4858342ea2756ea281cd0d99a3a
ToppCellnormal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass

TRERF1 KDM5C CD2AP DST HELZ RANBP2 DNAH10 ZCCHC8 COBLL1 MYB

1.20e-08174212102274648b80dd74f3c948a779bba3391095964c34
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

A2M RYR3 PCDH15 DMD UNC79 DNAH10 KIF26B PCLO ZFHX4 XIRP2

2.04e-08184212102cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

A2M RYR3 PCDH15 DMD UNC79 DNAH10 KIF26B PCLO ZFHX4 XIRP2

2.04e-08184212102b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

A2M RYR3 PCDH15 DMD UNC79 DNAH10 KIF26B PCLO ZFHX4 XIRP2

2.04e-0818421210ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

CHD2 BIRC6 UTRN RANBP2 ERO1B AHCTF1 DOCK10 ZNF407 PARP14 JMJD1C

2.51e-0818821210ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRIO STX3 KCTD16 PRUNE2 OXR1 KIF26B AKAP12 EGFR PARD3 L3MBTL4

2.91e-08191212101cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCellrenal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

TRIO CDK14 OXR1 AHCYL2 JMJD1C SIPA1L1 ANKRD17 PATJ PARD3 L3MBTL4

3.06e-0819221210e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ACTR3C CMYA5 DNAH14 PRUNE2 OXR1 COBLL1 PCLO PATJ PARD3 L3MBTL4

3.21e-08193212103866667dd221612589ae50f5c52f73a183a49ce6
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SOX5 CDK14 AHNAK BOD1L1 ERO1B COBLL1 PARP14 JMJD1C IFNGR2 SIPA1L1

3.54e-0819521210481989d2e5bd2582da3d86b0155c4d6615317067
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SOX5 CDK14 AHNAK BOD1L1 ERO1B COBLL1 PARP14 JMJD1C IFNGR2 SIPA1L1

3.54e-08195212106108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

A2M CHD2 PRRC2C DDX24 UTRN RNPC3 ZNF407 ZFC3H1 PARP14 PHF3

4.29e-0819921210f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCellLPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CTNNAL1 MAP4 PARVB KIDINS220 DST AHNAK KAT6A PARP14 ELK3 EPAS1

4.50e-08200212105c092b2ecc081b5d04476c56333c338cd89ab984
ToppCellLPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CTNNAL1 MAP4 PARVB KIDINS220 DST AHNAK KAT6A PARP14 ELK3 EPAS1

4.50e-082002121072ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCellCOVID-19|World / Disease, condition lineage and cell class

ILF3 PRRC2C AHNAK G3BP2 BOD1L1 DDX24 UTRN PARP14 SETD2 PHF3

4.50e-08200212107dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

A2M DST SUPT5H PARP2 ZNF407 KIAA1586 PARP14 EIF4EBP3 SDHAF4

1.26e-071692129665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

A2M DST SUPT5H PARP2 ZNF407 KIAA1586 PARP14 EIF4EBP3 SDHAF4

1.26e-0716921296614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

SOX5 ACTR3C ATP2C2 SELENBP1 COBLL1 CSF3R EGFR PATJ PARD3

2.47e-0718321296847c1252d6bb105524f812658112517fd351eab
ToppCellCOVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type

PARVB RARB COBLL1 DOCK10 AHCYL2 NCOA7 CRYBG3 LONRF2 SCIN

2.47e-0718321295c7597a5b2bf6a481ca2c7e68560179214150fa0
ToppCellCalu_3-infected|Calu_3 / Cell line, Condition and Strain

TRIO CD2AP CHD2 DST UTRN PARP14 JMJD1C SETD2 NCOA7

2.47e-0718321298f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP4 DMD UTRN NAA15 COPA JMJD1C SETD2 EGFR LTBP1

2.71e-071852129eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

PHACTR2 BIRC6 PIK3C2A BOD1L1 TRMT1L OXR1 USP37 GIGYF2 ASXL2

2.84e-07186212903db813598b67b1e08f759758a1c2023396921fa
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor

ACTR3C DNAH14 ATP2C2 COBLL1 PCLO AHCYL2 INO80 CSF3R NCOA7

3.10e-071882129ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCellPCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

ERBB3 ATP2C2 DMD COBLL1 PCLO PPL LRRC3B PATJ LONRF2

3.10e-0718821290d86044bc340e3efb90d0022dd299873639d831c
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRIO DNAH14 UTRN SDC2 PRUNE2 OXR1 PPL EGFR PARD3

3.10e-07188212963a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TRIO STX3 KCTD16 PRUNE2 OXR1 KIF26B AKAP12 PARD3 L3MBTL4

3.25e-0718921293b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCellChildren_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor

SOX5 DNAH14 ATP2C2 SELENBP1 COBLL1 EGFR PATJ PARD3 L3MBTL4

3.55e-071912129e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)

SOX5 CHD2 PRRC2C DDX24 RANBP2 JMJD1C SETD2 PHF3 OGA

3.55e-0719121291ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCellCD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster

A2M BIRC6 URB1 KIDINS220 AHCTF1 DOCK10 HEATR1 PARP14 PRKDC

3.55e-0719121299454f642c3621370fa23640b631301346b300950
ToppCellAdult-Epithelial|Adult / Lineage, Cell type, age group and donor

SOX5 DNAH14 ATP2C2 MLLT3 SELENBP1 COBLL1 EGFR PATJ PARD3

3.71e-071922129efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

TRIO KDM5C CDK14 AHNAK PCDH15 COBLL1 ZDBF2 PARP14 IFNGR2

3.87e-07193212908696a99309f5b088692ddac8cca35413b5e810d
ToppCellnucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SOX5 DNAH14 ATP2C2 SELENBP1 COBLL1 EGFR NCOA7 PATJ PARD3

4.22e-0719521299406866f99555198a9be311fbd65751b70f35446
ToppCellParenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations

SOX5 TRIO FMN1 DMD ZNF407 EGFR SIPA1L1 PARD3 L3MBTL4

4.80e-0719821291996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell(11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition

PHACTR2 CD2AP SEC16A BOD1L1 UTRN NAA15 PPP2R5E EGFR SBNO1

4.80e-07198212976d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCellSepsis-Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, condition lineage and cell class

CTNNAL1 TRIO SLC41A2 TNRC18 PDCL3 TAF5 DNAH10 ELK3 CRYBG3

5.01e-071992129a2be40d367338d32348a6906c8475aa3b544a0f7
ToppCellTracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations

SOX5 TRIO BIRC6 MLLT3 DMD UTRN ZNF407 PACS1 PARD3

5.01e-07199212994b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

PHACTR2 DST PRRC2C BOD1L1 UTRN PCLO PPP2R5E SBNO1 PHF3

5.01e-071992129c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCellLPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CTNNAL1 MAP4 KIDINS220 DST AHNAK KAT6A PARP14 ELK3 EPAS1

5.22e-07200212979e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCellLPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CTNNAL1 TRIO PARVB BIRC6 DST PIK3C2A UTRN ELK3 EPAS1

5.22e-072002129dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCellBac-SEP-Myeloid-tDC|Bac-SEP / Disease, Lineage and Cell Type

CTNNAL1 TRIO SLC41A2 DNAJC12 TAF5 DNAH10 ELK3 CRYBG3

1.30e-0616521288728f927502e56f2768b4224e9111939d3d7815a
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

CHD2 PRRC2C DDX24 UTRN RANBP2 KAT6A ZNF407 JMJD1C

1.69e-0617121282e9a20f8980b78325c52065a9c14ab3656267c05
ToppCelldroplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CMYA5 PRRC2C AHNAK DMD TASOR RANBP2 JMJD1C XIRP2

2.10e-061762128749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCellhuman_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

PARVB SLC41A2 PRUNE2 OXR1 ZFHX4 XIRP2 ELK3 CRYBG3

2.38e-06179212814fc8ccb6b215063d747643f47d780d2b237eb67
ToppCellMesenchymal_cells-Chondrocytes|Mesenchymal_cells / Lineage and Cell class

SOX5 NOG DNAH14 NGEF KIF26B WWP2 COBLL1 SCIN

2.48e-0618021286e399368430ef3afa9ce1ef0ed90f614ccef9987
ToppCellfacs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TEX2 IL18RAP SLC41A2 STX3 AHNAK TASOR DOCK10 IKBKB

2.59e-0618121287286700396676fdc41d9723979b8b408177aceb9
ToppCellCV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster

A2M BIRC6 URB1 KIDINS220 AHCTF1 DOCK10 HEATR1 PRKDC

3.04e-061852128a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCelldroplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CTNNAL1 BCR RYR3 TMCO4 RARB DNAH10 ACAD10 SUFU

3.04e-061852128bb5a4cf93534b9bcd0923f314c389d571e91e7f8
ToppCellCV-Moderate-7|CV / Virus stimulation, Condition and Cluster

A2M BIRC6 URB1 KIDINS220 AHCTF1 DOCK10 HEATR1 PRKDC

3.17e-0618621288571956890fc9894d766ba294a28e376b4aba428
ToppCellfacs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2AP DST ABCG2 UTRN PRUNE2 UBD LRRC3B ELK3

3.17e-0618621285302399825f213d105ac70b91366a4513b732838
ToppCellCOVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations)

A2M SOX5 DST DMD PRUNE2 KIF26B AKAP12 LTBP1

3.30e-061872128464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCellCOVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type

A2M BCR PDCD4 UTRN COBLL1 PARP14 LRRC3B EPAS1

3.30e-06187212840ffc06a3e3251d9b12da390210d3e045af7537a
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

NOG RYR3 PCDH15 DMD PRUNE2 LTBP1 RPE65 L3MBTL4

3.43e-06188212874f7d216209cabdc96b2d46685b0ae017fdcc8fc
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

NOG RYR3 DMD PRUNE2 KIF26B LTBP1 RPE65 L3MBTL4

3.57e-061892128da9ecc0d7b81c1901f30f97bb44112dc85444a66
ToppCellPBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters

HAUS6 BRCA2 TOPBP1 GINS4 USP37 PRKDC CLSPN CDC25A

3.71e-06190212884ee185939bdefb10705b621a70da27701eadcee
ToppCellPND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MAP4 DST AHNAK G3BP2 UTRN RTN4 KAT6A EPAS1

3.71e-061902128d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SOX5 ACTR3C DNAH14 FMN1 ATP2C2 AHCYL2 PATJ SCIN

3.86e-06191212834cc997e4e5c727495f321e6807a84aa124da486
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TRIO DNAH14 SDC2 OXR1 COBLL1 PPL EGFR PARD3

3.86e-061912128d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor

SOX5 ACTR3C ATP2C2 SELENBP1 COBLL1 CSF3R PATJ PARD3

3.86e-061912128a0332a4ef629510fb313ec119195c44a3f704a80
ToppCellEpithelial|World / Lineage, Cell type, age group and donor

SOX5 DNAH14 ATP2C2 SELENBP1 COBLL1 EGFR PATJ PARD3

4.01e-061922128499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SOX5 ACTR3C DNAH14 FMN1 ATP2C2 CSF3R PATJ SCIN

4.01e-061922128fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCellnucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TRIO CDK14 BIRC6 FMN1 UTRN JMJD1C SIPA1L1 ANKRD17

4.16e-061932128779276e775cb2492e8dd36436295a536084a6415
ToppCellnucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SOX5 DNAH14 SELENBP1 COBLL1 EGFR NCOA7 PATJ PARD3

4.33e-06194212853f3e49e91b1096f3226010e2de767efb490dfe4
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ACTR3C DNAH14 OXR1 COBLL1 PCLO PATJ PARD3 SCIN

4.33e-0619421285eaaa81f4b2535f983c424aaef00077089526a5c
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

TRERF1 SOX5 DST SDC2 RARB DOCK10 ZFHX4 EGFR

4.33e-061942128b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CD2AP CMYA5 DNAH14 PRUNE2 OXR1 PATJ PARD3 L3MBTL4

4.33e-0619421287002937e8903e037332a215d00fbc7c7843b33f2
ToppCell(08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition

CD2AP PRRC2C BOD1L1 RARB SBNO1 NEMF ANKRD17

4.49e-061382127817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

A2M SOX5 SDC2 LRRC8E RARB RARG ZFHX4 SCIN

4.49e-06195212830ed961151b8b1f6ce37f06c9a061519f01c2864
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

TRERF1 SOX5 DST SDC2 RARB DOCK10 ZFHX4 EGFR

4.49e-0619521280e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCellBronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations

SOX5 MLLT3 DMD ZNF407 HIVEP3 SIPA1L1 PARD3 L3MBTL4

4.66e-061962128ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCellfacs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RYR3 PCDH15 DMD SDC2 DNAH10 ZFHX4 EGFR LTBP1

4.66e-0619621286bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCellfacs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RYR3 PCDH15 DMD SDC2 DNAH10 ZFHX4 EGFR LTBP1

4.66e-061962128c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCellsevere-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

PRRC2C MLLT3 DDX24 UTRN RNPC3 ZDBF2 ZFC3H1 AKAP12

4.84e-06197212857ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCellCOVID-19_Mild|World / Disease group, lineage and cell class

PRRC2C BOD1L1 DDX24 UTRN PARP14 JMJD1C PHF3 OGA

4.84e-0619721285c33454b10023decd2f5ccda9229b6512659711e
ToppCellH1299-infected-SARSCoV2|infected / Cell line, Condition and Strain

CHD2 PRRC2C AHNAK BOD1L1 ZFC3H1 NEMF CLSPN OGA

4.84e-0619721280fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PHACTR2 DNAJC12 MLLT3 SDC2 RARB KIF26B AKAP12 ZFHX4

4.84e-061972128fc718a254bda4df2d62975d04393492fb75ab305
ToppCellPBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)

PRRC2C BOD1L1 DDX24 UTRN PARP14 JMJD1C PHF3 OGA

5.03e-06198212844417089b62056269cac38d3134ff209c05b7007
ToppCellPBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PRRC2C BOD1L1 DDX24 UTRN PARP14 JMJD1C PHF3 OGA

5.03e-06198212828ef3fc4c17dcb765537b75917f7db78baa522db
ToppCellBronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DNAH14 FMN1 ATP2C2 COBLL1 CSF3R EGFR PARD3 L3MBTL4

5.22e-0619921285f7da3eab58ace6cddb3179a415cd839d5767958
ToppCellParenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DNAH14 FMN1 ATP2C2 COBLL1 CSF3R EGFR PARD3 L3MBTL4

5.22e-0619921285cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell(04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition

PHACTR2 CD2AP PRRC2C BOD1L1 NAA15 PPP2R5E SBNO1 NCOA7

5.22e-06199212853ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell(10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition

CD2AP SAMD15 PRRC2C BOD1L1 NAA15 PPP2R5E SBNO1 NEMF

5.22e-06199212861b1ed2db71b96157b92b7535d1955a4033098da
ToppCellParenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ACTR3C DNAH14 FMN1 ATP2C2 COBLL1 CSF3R EGFR PARD3

5.22e-0619921288587bd98de7767a575088afbea07a1feb4516b9b
ToppCellLPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type

CTNNAL1 PARVB BCR PIK3C2A KAT6A PARP14 ELK3 EPAS1

5.41e-062002128edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCellLPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CTNNAL1 PARVB BCR DST AKR1B10 MLLT3 LTBP1 EPAS1

5.41e-062002128b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCellcontrol|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ERBB3 DST AHNAK PCLO PPL C6orf132 EGFR EPAS1

5.41e-06200212897f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCellNS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ERBB3 DST AHNAK PCLO PPL C6orf132 EGFR EPAS1

5.41e-062002128ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCellAdult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor

CTNNAL1 RYR3 SACS DMD PRUNE2 AKAP12 LTBP1

1.23e-05161212764891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

TRIO CDK14 AHNAK COBLL1 PARP14 JMJD1C SIPA1L1

1.34e-0516321276bed27d2f67a430a847da5eb47878d14b4949c45
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

A2M SOX5 DMD PRUNE2 KIF26B PCDHB2 LTBP1

1.39e-051642127e3983f655cdba308fb192182829f17bef99ce0ba
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KCTD16 SDC2 PRUNE2 OXR1 AKAP12 EGFR RPE65

1.39e-051642127382e42701779d12a7948690b3be72d06dd75c8b4
ToppCellwk_15-18-Hematologic-Myeloid-HSC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

NOG FERMT3 CCNB1 XIRP2 EIF4EBP3 IL1B MYB

1.56e-0516721275f793eafbb593317caa9afd8267e561e09058ddb
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SACS AHNAK AHCTF1 DOCK10 PRKDC PATJ OGA

1.56e-05167212783969c36ac44b96afc9aa09400a99fa2b487f7ff
ToppCellE16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TEX2 URB1 FERMT3 DOCK10 HEATR1 INF2 CRYBG3

1.69e-051692127305cedbd97059029d7d2a248a8a4b6cfe281aa54
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

TRIO CDK14 AHNAK COBLL1 PARP14 JMJD1C SIPA1L1

1.96e-051732127d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCelldroplet-Kidney-KIDNEY-30m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BRCA2 SUPT7L PPL AKAP12 PRKDC PATJ SUFU

2.11e-05175212731f0fb2e47e357dbf9c15436b7df85b3c370ded7
DrugEucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A

KDM5C MAML1 PDCD4 KIDINS220 ATP2C2 UTRN SDC2 NUMA1 SH3D21 ZFHX4 SUGP1 PARD3 OGA

3.91e-08196211133416_UP
DrugPronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A

PHACTR2 ILF3 MAP4 PRRC2C FKBP15 KAT6A NUMA1 GINS4 SETD2 PHF3 SUGP1 LTBP1

2.51e-07192211124104_DN
DrugPyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; PC3; HT_HG-U133A

KDM5C PARVB ZNF318 STX1A TRMT1L PCLO PPL HIVEP3 PHF3 SUGP1 PARD3 IL1B

2.97e-07195211126339_DN
DrugBuspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; HL60; HT_HG-U133A

IL18RAP MAP3K12 G3BP2 MLLT3 UTRN COPA ACTR3B ZFHX4 INF2 SUGP1 IKBKB OGA

3.32e-07197211121282_UP
Drug1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one

ERBB3 PIK3C2A PIK3C3 ABCG2 EGFR PRKDC

6.39e-07342116ctd:C569670
DrugEthotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A

ILF3 MAP4 NAA15 COPA PCLO KAT6A GINS4 SETD2 EGFR PHF3 RNF146

1.54e-06188211114545_DN
DrugNeostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A

PHACTR2 ILF3 MAP4 PRRC2C DDX24 UTRN NAA15 PCLO EGFR PHF3 LTBP1

1.54e-06188211116735_DN
DrugHesperetin [520-33-2]; Down 200; 13.2uM; PC3; HT_HG-U133A

PHACTR2 ILF3 TRIO STX3 BRCA2 HELZ UTRN NUMA1 FCF1 SUGP1 CDC25A

1.62e-06189211116750_DN
DrugAmpyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A

MAP4 PRRC2C METTL16 UTRN KAT6A GINS4 AHCYL2 FCF1 EGFR SBNO1 PHF3

1.71e-06190211114507_DN
DrugAcetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; HL60; HG-U133A

MAP4 KDM5C AHNAK UTRN SDC2 AHCYL2 OVGP1 INF2 RNF146 CDC25A OGA

2.09e-06194211111377_DN
DrugBiotin [58-85-5]; Down 200; 16.4uM; PC3; HT_HG-U133A

SUPT5H ATP2C2 ABCG2 PLXNA3 COPA NUMA1 AHCYL2 HIVEP3 SUGP1 OGA RAI2

2.20e-06195211116689_DN
Drugnovobiocin sodium, USP; Down 200; 100uM; SKMEL5; HG-U133A

TRIO MAP4 TBCC COPA ZCCHC8 NUMA1 SETD2 SF3B3 PARD3 CDC25A PUS7L

2.20e-0619521111632_DN
DrugPergolide mesylate [66104-23-2]; Up 200; 9.8uM; PC3; HT_HG-U133A

TRIO KIDINS220 METTL16 UTRN RARG NUMA1 SF3B3 EGFR PHF3 PARD3 CDC25A

2.31e-06196211117271_UP
DrugFlucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A

KDM5C PDCD4 COBLL1 ACAD10 AHCYL2 HIVEP3 EGFR INF2 SIPA1L1 SUGP1 IL1B

2.43e-06197211116507_DN
DrugBethanechol chloride [590-63-6]; Down 200; 20.4uM; MCF7; HT_HG-U133A

MAP3K12 KIDINS220 G3BP2 SDC2 PLXNA3 RARG COBLL1 NUMA1 ACAD10 SUGP1 PARD3

2.55e-06198211113537_DN
DrugAztreonam [78110-38-0]; Down 200; 9.2uM; PC3; HT_HG-U133A

BCR METTL16 UTRN RARG COPA PCLO NUMA1 FCF1 EGFR CDC25A SCIN

2.55e-06198211115110_DN
DrugSulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A

TRIO MAP4 KDM5C LRRC8E COPA ACAD10 SUGP1 LTBP1 IL1B CDC25A OGA

2.55e-06198211114979_DN
DrugNilutamide [63612-50-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A

PARVB ZNF318 METTL16 FKBP15 COPA COBLL1 ACAD10 AHCYL2 EGFR SUGP1 IL1B

2.55e-06198211116481_DN
DrugSuccimer

HAUS6 ZNF280D IL18RAP PDCD4 PRAM1 BRCA2 SACS FMN1 AHNAK HELZ UTRN SELENBP1 RTN4 TOPBP1 DOCK10 ZFC3H1 USP37 JMJD1C HIVEP3 ZFHX4 EGFR PHF3 NEMF GIGYF2 CLSPN IL1B SCIN ZMYM3 MYB

6.15e-06126421129ctd:D004113
DrugEtifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A

PHACTR2 ILF3 MAP4 PRRC2C DDX24 NAA15 PCLO EGFR PHF3 LTBP1

6.64e-06178211103998_DN
Drugretinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA

BCR AHNAK ATP2C2 METTL16 WDR44 ACTR3B MTMR4 PHF3 PARD3 CDC25A

9.33e-06185211101049_DN
Druggeldanamycin

PHACTR2 CDK14 DST PRRC2C BOD1L1 METTL16 DMD KAT6A HEATR1 JMJD1C SETD2 ZFHX4 EGFR IL1B

1.03e-0537121114ctd:C001277
Drug4-anilinoquinazoline

ERBB3 BCR ABCG2 EGFR

1.20e-05162114CID000324081
DrugMagnetite Nanoparticles

HAUS6 ZNF280D IL18RAP PDCD4 PRAM1 BRCA2 SACS FMN1 AHNAK HELZ UTRN SELENBP1 RTN4 TOPBP1 DOCK10 ZFC3H1 USP37 JMJD1C HIVEP3 ZFHX4 EGFR PHF3 NEMF GIGYF2 CLSPN IL1B SCIN ZMYM3 MYB

1.21e-05131021129ctd:D058185
Drugtamibarotene

CTNNAL1 ILF3 TRIO STX1A DST BRCA2 SACS PRRC2C AHNAK SEC16A RARB RARG ANKRD17 PRKDC IL1B CDC25A OGA MYB

1.22e-0559621118ctd:C061133
DrugFenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A

TRIO URB1 BRCA2 ATP2C2 KAT6A NUMA1 HIVEP3 SETD2 EGFR SUGP1

1.23e-05191211104279_DN
DrugPhenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A

MAP4 PRRC2C ATP2C2 KAT6A NUMA1 GINS4 FCF1 PHF3 LTBP1 OGA

1.23e-05191211104283_DN
DrugClorgyline hydrochloride [17780-75-5]; Down 200; 13uM; PC3; HT_HG-U133A

TRIO URB1 KIDINS220 METTL16 COPA HIVEP3 ELK3 PATJ IL1B EPAS1

1.29e-05192211106659_DN
DrugGlycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A

ILF3 KIDINS220 BRCA2 HELZ UTRN FKBP15 FCF1 SUGP1 PRKDC CDC25A

1.35e-05193211106716_DN
DrugAlbendazole [54965-21-8]; Up 200; 15uM; HL60; HG-U133A

PHACTR2 CD2AP CDK14 IL18RAP SDC2 AHCYL2 SETD2 OVGP1 SUGP1 ELK3

1.35e-05193211101547_UP
DrugGallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A

MAP4 SDC2 WWP2 SF3B3 SIPA1L1 LTBP1 ELK3 IKBKB CDC25A ZMYM3

1.35e-05193211106215_DN
DrugNorgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A

UTRN RARG COPA COBLL1 KAT6A SETD2 PHF3 SUGP1 CDC25A RAI2

1.41e-05194211103606_DN
DrugH-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A

PHACTR2 ILF3 TRIO CDK14 PDCD4 ATP2C2 PCLO PHF3 SUGP1 LTBP1

1.41e-05194211106921_UP
Drug(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A

MAP4 KDM5C MAML1 MAP3K12 COBLL1 ACTR3B HIVEP3 SUGP1 PARD3 OGA

1.41e-05194211103539_DN
DrugFlutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A

PHACTR2 ILF3 MAP4 PRRC2C METTL16 LRRC8E NAA15 NUMA1 PHF3 LTBP1

1.41e-05194211104361_DN
DrugFenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A

ILF3 TRIO MAP3K12 KIDINS220 BRCA2 HELZ UTRN RARG DOCK10 SUGP1

1.48e-05195211103721_DN
DrugAtropine-N-oxide hydrochloride [4574-60-1]; Up 200; 11.8uM; HL60; HG-U133A

PHACTR2 ZNF280D PDCD4 STX1A BRCA2 PIK3C2A JMJD1C SBNO1 IL1B OGA

1.48e-05195211101370_UP
DrugTroleandomycin [2751-09-9]; Down 200; 5uM; MCF7; HT_HG-U133A

KIDINS220 SUPT7L MLLT3 METTL16 UTRN FKBP15 RARG PACS1 SUGP1 ELK3

1.54e-05196211101465_DN
DrugAllantoin [97-59-6]; Down 200; 25.2uM; PC3; HT_HG-U133A

TRIO URB1 METTL16 FKBP15 RARG COPA FCF1 PACS1 EGFR EPAS1

1.54e-05196211105052_DN
DrugClozapine [5786-21-0]; Up 200; 12.2uM; HL60; HT_HG-U133A

ZNF318 IL18RAP MAP3K12 MLLT3 UTRN WDR44 NUMA1 MTMR4 SIPA1L1 SUGP1

1.54e-05196211101289_UP
DrugTiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A

MAP4 URB1 STX1A METTL16 FKBP15 KAT6A HIVEP3 PACS1 EGFR SUGP1

1.61e-05197211102259_DN
DrugParbendazole [14255-87-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A

CDK14 URB1 AHNAK PRUNE2 ERO1B COBLL1 PCLO SH3D21 SUGP1 EPAS1

1.61e-05197211103881_UP
DrugBuspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A

MAP4 MAP3K12 SUPT7L ATP2C2 RARG AKAP12 INF2 SUGP1 PATJ PARD3

1.61e-05197211105343_DN
DrugTalampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A

MAML1 PDCD4 KIDINS220 SDC2 PLXNA3 RARG ACAD10 EGFR PATJ PARD3

1.61e-05197211103515_DN
DrugDeferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A

TRIO MAP4 ZNF318 SUPT7L LRRC8E FKBP15 RARG SETD2 SF3B3 SUGP1

1.61e-05197211103417_DN
DrugMeclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A

MAP4 MAP3K12 METTL16 COBLL1 ZNF407 SETD2 ZNF35 PHF3 SUGP1 RAI2

1.69e-05198211104729_DN
DrugZimelidine dihydrochloride monohydrate [61129-30-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A

TRIO MAP4 STX1A AHNAK SDC2 LRRC8E RARB COPA KAT6A OVGP1

1.69e-05198211101512_UP
DrugMethazolamide [554-57-4]; Down 200; 17uM; MCF7; HT_HG-U133A

ZNF280D TRIO NACA PDCD4 PRRC2C SUPT7L ATP2C2 PPL IKBKB CDC25A

1.76e-05199211106268_DN
DrugLevocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A

TRIO MAP4 METTL16 RARG JMJD1C SETD2 INF2 SIPA1L1 SUGP1 CDC25A

1.76e-05199211107009_DN
DrugPHA-00846566E [724718-26-7]; Up 200; 10uM; MCF7; HT_HG-U133A

MAP4 SDC2 RARG COPA PACS1 INF2 PHF3 PATJ CDC25A OGA

1.76e-05199211107081_UP
DrugLevopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A

KDM5C MAP3K12 PDCD4 KIDINS220 HELZ SDC2 COBLL1 SUGP1 IL1B OGA

1.76e-05199211103543_DN
DrugScopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A

CD2AP TTBK2 ATP2C2 SDC2 COBLL1 KAT6A GINS4 HIVEP3 SIPA1L1 IKBKB

1.76e-05199211104803_DN
Drugtorcetrapib

PHACTR2 ILF3 MAP4 CDK14 DST PRRC2C DNAJC12 BOD1L1 METTL16 NAA15 AHCTF1 HEATR1 LONRF2

1.99e-0534221113ctd:C483909
DrugE-PEG

ERBB3 BCR BIRC6 MAP3K12 PIK3C2A PIK3C3 MLLT3 ABCG2 PARP2 KAT6A NUMA1 CCNB1 APIP SETD2 EGFR PRKDC IKBKB CDC25A

2.10e-0562121118CID000003310
DrugK00014

ABCG2 CCNB1 CCNB3 IKBKB CDC25A

2.55e-05382115CID000004987
DrugERK inhibitor

IL18RAP PIK3C2A PIK3C3 SUPT7L AKAP12 SETD2 EGFR IL1B CDC25A

2.56e-051662119CID001249835
DrugPX-866

ERBB3 PIK3C2A PIK3C3 EGFR

3.09e-05202114CID009849735
Drug2,3-bis(3'-hydroxybenzyl)butyrolactone

TRERF1 PHACTR2 CTNNAL1 CHD2 PDCD4 STX3 KIDINS220 BRCA2 PIK3C3 PRRC2C G3BP2 TAF5 PARP2 TOPBP1 GINS4 PPL CCNB1 MTMR4 SF3B3 NCOA7 PRKDC CDC25A MYB

3.18e-0596121123ctd:C029497
Drug3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol

PHACTR2 ABCF3 NACA PARVB G3BP2 HELZ SELENBP1 INF2 PRPF3 ASXL2 IL1B ZMYM3

3.94e-0531421112ctd:C572491
DrugCamptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A

MARK3 STX3 TAF5 KAT6A COX10 JMJD1C SETD2 PHF3 GIGYF2

4.84e-0518021194541_DN
Drug0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A

ZNF318 BRCA2 MLLT3 TAF5 TMEM186 ASXL2 CDC25A PUS7L MYB

5.27e-0518221193630_DN
DrugGW8510; Down 200; 10uM; MCF7; HT_HG-U133A

BRCA2 PIK3C3 TAF5 TBCC ZCCHC8 PARP2 JMJD1C CDC25A MYB

5.50e-0518321197062_DN
DrugDicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A

TRIO MAP4 METTL16 ERO1B KAT6A NUMA1 GINS4 EGFR PHF3

6.50e-0518721194323_DN
DrugSelenomethionine

PARVB DST WWP2 EGFR IKBKB IL1B L3MBTL4

6.71e-051082117ctd:D012645
DrugNSC683246

TRIO CDK14 PDCD4 CCNB1 EGFR CCNB3 IKBKB CDC25A EPAS1 MYB

6.96e-0523421110CID000005097
DrugPempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A

A2M PHACTR2 MAP4 COPA KAT6A NUMA1 HIVEP3 PHF3 IKBKB

7.65e-0519121193926_DN
DrugPipemidic acid [51940-44-4]; Down 200; 13.2uM; PC3; HT_HG-U133A

ILF3 BRCA2 FCF1 PACS1 PHF3 IKBKB CDC25A SCIN EPAS1

7.96e-0519221196752_DN
DrugErgocryptine-alpha [511-09-1]; Up 200; 7uM; HL60; HT_HG-U133A

PDCD4 URB1 KIDINS220 SDC2 DOCK10 AHCYL2 SIPA1L1 IL1B EPAS1

7.96e-0519221192572_UP
Druggenistein; Down 200; 10uM; MCF7; HT_HG-U133A

ZNF318 FKBP15 RARG COBLL1 NUMA1 GINS4 FCF1 RNF146 OGA

8.28e-0519321195232_DN
DrugMethylergometrine maleate [113-42-8]; Down 200; 8.8uM; PC3; HT_HG-U133A

ILF3 ZNF318 NUMA1 FCF1 PHF3 SUGP1 PRKDC PARD3 OGA

8.28e-0519321196704_DN
DrugColchicine [64-86-8]; Down 200; 10uM; MCF7; HT_HG-U133A

PDCD4 SUPT7L FKBP15 NUMA1 AKAP12 FCF1 ZNF35 RNF146 OGA

8.28e-0519321193213_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A

TRIO MAML1 URB1 RARG OVGP1 EGFR SUGP1 PDCD11 CDC25A

8.28e-0519321195239_DN
Drug4-carboxyphenylretinamide

RARB RARG

8.55e-0522112CID006439748
DrugMoroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; PC3; HT_HG-U133A

ILF3 TRIO PDCD4 METTL16 FKBP15 KAT6A FCF1 PRKDC RAI2

8.62e-0519421196705_DN
DrugMenadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A

TRIO TTBK2 SUPT7L METTL16 TASOR DOCK10 FCF1 PHF3 PRKDC

8.62e-0519421194662_DN
DrugSulfaguanidine [57-67-0]; Down 200; 18.6uM; MCF7; HT_HG-U133A

ILF3 MAP4 BCR HELZ NUMA1 FCF1 OVGP1 SUGP1 IKBKB

8.62e-0519421194839_DN
DrugFlufenamic acid [530-78-9]; Down 200; 14.2uM; PC3; HT_HG-U133A

ZNF280D CDK14 TTBK2 STX3 LRRC8E RARG AHCYL2 PHF3 PUS7L

8.96e-0519521192104_DN
DrugBenfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A

STX3 METTL16 RARG COPA ACAD10 FCF1 EGFR SIPA1L1 RNF146

8.96e-0519521192621_DN
Drug(R)-Propranolol hydrochloride [13071-11-9]; Down 200; 13.6uM; PC3; HT_HG-U133A

MAP4 KDM5C URB1 BRCA2 AHCYL2 HIVEP3 PHF3 SIPA1L1 SUGP1

8.96e-0519521195814_DN
DrugCarbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A

RARG PCLO KAT6A FCF1 EGFR PHF3 ELK3 IKBKB OGA

8.96e-0519521195093_DN
DrugAzathymine, 6 [932-53-6]; Down 200; 31.4uM; MCF7; HT_HG-U133A

MAP4 PDCD4 SDC2 KAT6A GINS4 ACAD10 OVGP1 SIPA1L1 OGA

8.96e-0519521194106_DN
DrugTrimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A

MAP4 STX1A KIDINS220 COBLL1 OVGP1 EGFR SUGP1 ELK3 CDC25A

8.96e-0519521194180_DN
DrugCefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A

MAML1 KIDINS220 PRRC2C DDX24 NUMA1 SETD2 PHF3 SUGP1 EPAS1

8.96e-0519521196159_DN
DrugSulfamethoxypyridazine [80-35-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A

TRIO PLXNA3 NUMA1 SH3D21 PACS1 PHF3 DNAH17 SUGP1 CDC25A

9.32e-0519621193409_UP
DrugGuaifenesin [93-14-1]; Up 200; 20.2uM; HL60; HT_HG-U133A

KIDINS220 ABCG2 PRUNE2 PLXNA3 COBLL1 PCLO AHCYL2 ZFHX4 EPAS1

9.32e-0519621192569_UP
DrugPhenformin hydrochloride [834-28-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A

MAML1 KIDINS220 UTRN COPA ZNF407 PACS1 ZNF35 SUGP1 RAI2

9.32e-0519621194747_DN
Drughaloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA

ILF3 MAP4 KDM5C PDCD4 MLLT3 RARG JMJD1C INF2 ZMYM3

9.32e-0519621191082_UP
DrugBuflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A

MAP4 STX3 PLXNA3 RARG GINS4 FCF1 PACS1 OVGP1 SUGP1

9.32e-0519621194840_DN
DrugBromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; PC3; HT_HG-U133A

ZNF318 MAP3K12 STX1A INF2 PHF3 SUGP1 PRKDC CDC25A SCIN

9.69e-0519721194604_DN
DrugGallamine triethiodide [65-29-2]; Up 200; 4.4uM; PC3; HT_HG-U133A

SUPT7L ABCG2 UTRN FKBP15 FCF1 OVGP1 EGFR PHF3 SUGP1

9.69e-0519721192059_UP
DrugMeclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A

MAP3K12 UTRN NUMA1 ZFHX4 DNAH17 SUGP1 PARD3 IL1B CDC25A

9.69e-0519721195244_DN
DrugCefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A

KDM5C KIDINS220 COBLL1 KAT6A ACAD10 HIVEP3 INF2 SIPA1L1 LTBP1

9.69e-0519721192235_DN
DrugTodralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; PC3; HT_HG-U133A

ZNF280D PDCD4 UTRN NUMA1 ACAD10 PPL FCF1 INF2 SCIN

9.69e-0519721195087_DN
DrugSuccinylsulfathiazole [116-43-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A

ILF3 MAP4 MARK3 BCR SUPT7L SDC2 NUMA1 PACS1 SUGP1

9.69e-0519721194847_DN
DrugDydrogesterone [152-62-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A

ZNF318 BCR TTBK2 STX1A G3BP2 SDC2 RARG AKAP12 SUGP1

9.69e-0519721194836_DN
Drugprostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A

PARVB MAP3K12 PDCD4 FKBP15 NUMA1 ACTR3B FCF1 OVGP1 RAI2

9.69e-0519721196547_DN
DrugMevalonic-D, L acid lactone [674-26-0]; Up 200; 30.8uM; MCF7; HT_HG-U133A

TRIO MAP4 PDCD4 BRCA2 UTRN ZNF407 EGFR SIPA1L1 CDC25A

9.69e-0519721193459_UP
DrugFluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A

KDM5C ZNF318 MAP3K12 LRRC8E PLXNA3 RARG PACS1 SUGP1 CDC25A

9.69e-0519721195356_DN
Drugaspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A

PHACTR2 ZNF318 HELZ FKBP15 RARG SETD2 EGFR CDC25A OGA

9.69e-0519721195201_DN
DrugPromethazine hydrochloride [58-33-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A

MAP4 ZNF318 MAP3K12 KIDINS220 UTRN EGFR SUGP1 CDC25A EPAS1

9.69e-0519721195317_UP
DiseaseMalignant neoplasm of breast

TRERF1 ERBB3 DDX59 ZNF318 PDCD4 BRCA2 G3BP2 BOD1L1 ABCG2 DMD ALDOA RARB RARG UBD AKAP12 SETD2 EGFR LRRC3B SBNO1 SIPA1L1 ELK3 IKBKB CLSPN IL1B

5.64e-07107420624C0006142
DiseaseOsteoarthritis, Knee

WWP2 SBNO1 LTBP1

1.33e-0642063C0409959
Diseaseuric acid measurement

SOX5 CHD2 ZNF318 BIRC6 FMN1 HFM1 ABCG2 COBLL1 ACAD10 PACS1 SUGP1 NCOA7 ASXL2 EPAS1 ZMYM3

2.80e-0561020615EFO_0004761
Diseasecerebellar hyplasia/atrophy, epilepsy, and global developmental delay (implicated_via_orthology)

OXR1 NCOA7

4.85e-0522062DOID:0070339 (implicated_via_orthology)
Diseasetriglycerides in small VLDL measurement

STX1A DNAH10 COBLL1 JMJD1C SUGP1

6.84e-05612065EFO_0022145
Diseasefree cholesterol in very large VLDL measurement

STX1A DNAH10 COBLL1 JMJD1C SUGP1

6.84e-05612065EFO_0022274
Diseasetriglycerides to total lipids in very large HDL percentage

STX1A COBLL1 JMJD1C RNF146 SUGP1

7.40e-05622065EFO_0022339
Diseasetotal lipids in very large VLDL measurement

STX1A DNAH10 COBLL1 JMJD1C SUGP1

7.40e-05622065EFO_0022313
Diseasephospholipids in very large VLDL measurement

STX1A DNAH10 COBLL1 JMJD1C SUGP1

7.40e-05622065EFO_0022299
DiseaseMammary Carcinoma, Human

TRERF1 ERBB3 BRCA2 ABCG2 ALDOA RARB UBD AKAP12 SETD2 EGFR LRRC3B ELK3 IL1B

8.99e-0552520613C4704874
DiseaseMammary Neoplasms, Human

TRERF1 ERBB3 BRCA2 ABCG2 ALDOA RARB UBD AKAP12 SETD2 EGFR LRRC3B ELK3 IL1B

8.99e-0552520613C1257931
DiseaseMammary Neoplasms

TRERF1 ERBB3 BRCA2 ABCG2 ALDOA RARB UBD AKAP12 SETD2 EGFR LRRC3B ELK3 IL1B

9.34e-0552720613C1458155
DiseaseLung Neoplasms

A2M ERBB3 PDCD4 BRCA2 RARB SELENBP1 SOX30 EGFR IL1B

1.10e-042652069C0024121
DiseaseMalignant neoplasm of lung

A2M ERBB3 PDCD4 BRCA2 RARB SELENBP1 SOX30 EGFR IL1B

1.13e-042662069C0242379
DiseaseBreast Carcinoma

TRERF1 ERBB3 BRCA2 ABCG2 ALDOA RARB UBD AKAP12 SETD2 EGFR LRRC3B ELK3 IL1B

1.15e-0453820613C0678222
Diseasetriglycerides to phosphoglycerides ratio

STX1A DNAH10 COBLL1 JMJD1C SUGP1

1.15e-04682065EFO_0022327
Diseasecardiotoxicity, response to anthracycline-based chemotherapy

ILF3 PRUNE2 RARG

1.15e-04142063EFO_0005257, EFO_1001482
Diseasephosphatidylcholine 38:6 measurement

AHCTF1 SUGP1 LTBP1

1.76e-04162063EFO_0010388
Diseaselymphocyte count

ERBB3 MARK3 BCR IL18RAP AHNAK HELZ HFM1 FERMT3 SELENBP1 DNAH10 PCDHGA2 WWP2 COBLL1 RTN4 TRIM31 DOCK10 ACAD10 JMJD1C SETD2 EGFR SBNO1 DNAH17 MYB

2.48e-04146420623EFO_0004587
DiseaseMalignant Neoplasms

ERBB3 BIRC6 AKR1B10 SETD2 EGFR IL1B

2.88e-041282066C0006826
Diseaseplatelet component distribution width

MARK3 CD2AP PRRC2C MLLT3 PRUNE2 RARB COBLL1 DOCK10 JMJD1C SETD2 EGFR SUGP1 SDHAF4 EPAS1 MYB

2.93e-0475520615EFO_0007984
DiseaseNeoplasm Invasiveness

PDCD4 AHNAK AKR1B10 DMD ALDOA EGFR IL1B

3.25e-041842067C0027626
Diseaselung adenocarcinoma (is_implicated_in)

ERBB3 RARB SETD2 EGFR

3.82e-04492064DOID:3910 (is_implicated_in)
DiseaseProstatic Neoplasms

ERBB3 BRCA2 KAT6A RFX6 AHCYL2 PPL SETD2 EGFR NCOA7 PRKDC PATJ PARD3 ZMYM3

4.23e-0461620613C0033578
DiseaseMalignant neoplasm of prostate

ERBB3 BRCA2 KAT6A RFX6 AHCYL2 PPL SETD2 EGFR NCOA7 PRKDC PATJ PARD3 ZMYM3

4.23e-0461620613C0376358
DiseaseColorectal Carcinoma

SACS AKR1B10 ABCG2 DMD RARB SELENBP1 RTN4 AKAP12 HIVEP3 OVGP1 EGFR LRRC3B CCNB3 LONRF2

4.49e-0470220614C0009402
DiseaseNeurodevelopmental Disorders

TRIO CHD2 HIVEP3 SETD2 GIGYF2

4.99e-04932065C1535926
Diseasebrain measurement, neuroimaging measurement

SOX5 ERBB3 ABCF3 MARK3 ABCG2 KIF26B EGFR SBNO1 PRPF3 SUGP1 PARD3 SUFU

5.24e-0455020612EFO_0004346, EFO_0004464
Diseasetriglycerides in large VLDL measurement

STX1A DNAH10 COBLL1 JMJD1C

6.38e-04562064EFO_0022178
Diseasetriglycerides in very large VLDL measurement

STX1A COBLL1 JMJD1C SUGP1

6.38e-04562064EFO_0022325
Diseasecreatinine measurement

SOX5 NOG CHD2 BIRC6 PRRC2C PIP5K1A ABCG2 RARB KIF26B ACAD10 INO80 NCOA7 GIGYF2 ASXL2 PARD3 SUFU EPAS1

6.57e-0499520617EFO_0004518
DiseaseAdenoid Cystic Carcinoma

KAT6A JMJD1C SETD2 PRKDC MYB

6.95e-041002065C0010606
Diseasechronic obstructive pulmonary disease, CC16 measurement

AHNAK APIP

7.14e-0462062EFO_0000341, EFO_0005080
DiseasePleocytosis

CSF3R IL1B

7.14e-0462062C0151857
DiseaseMEDULLOBLASTOMA

BRCA2 SUFU

7.14e-0462062155255
DiseaseMedulloblastoma

BRCA2 SUFU

7.14e-0462062cv:C0025149
DiseaseLeukocytosis

CSF3R IL1B

7.14e-0462062C0023518
Diseaseeosinophil count

TRERF1 ERBB3 CATSPER3 IL18RAP SAMD15 TRMT10C SUPT5H SEC16A HFM1 ALDOA RARB UBD WWP2 TRIM31 RFX6 ACAD10 HIVEP3 GRPEL1 SETD2 PRKDC SUFU MYB

7.65e-04148820622EFO_0004842
Diseasetriglycerides in VLDL measurement

STX1A COBLL1 JMJD1C SUGP1

7.78e-04592064EFO_0022326
Diseaseeosinophil percentage of leukocytes

TRERF1 IL18RAP TRMT10C ALDOA RARB TRIM31 RFX6 JMJD1C HIVEP3 GRPEL1 SETD2 CSF3R PRKDC MYB

8.11e-0474620614EFO_0007991
DiseaseC-reactive protein measurement

TRERF1 SOX5 IL18RAP AHNAK SEC16A PCDH15 HFM1 ABCG2 SF3B2 RARB OXR1 COBLL1 PPL PACS1 SBNO1 RNF146 DNAH17 PATJ IL1B

8.44e-04120620619EFO_0004458
Diseaseimmature platelet count

CD2AP DOCK10 JMJD1C SETD2 MYB

9.05e-041062065EFO_0803544
DiseaseAlzheimer disease, polygenic risk score

CD2AP DNAH14 FSIP2 DST UBD ZCCHC8 PCDHGA2 RFX6 SF3B3 SBNO1 PHF3 SCIN

9.09e-0458620612EFO_0030082, MONDO_0004975
Diseasetriglycerides in small HDL measurement

STX1A COBLL1 JMJD1C SUGP1

9.38e-04622064EFO_0022158
Diseasephospholipids in large VLDL measurement

STX1A DNAH10 COBLL1 JMJD1C

9.38e-04622064EFO_0022169
Diseasecutaneous melanoma, hair color

MARK3 BCR AHNAK AKAP12

9.38e-04622064EFO_0000389, EFO_0003924
Diseasesusceptibility to rheumatic fever measurement

MAML1 RYR3 CDC25A

9.66e-04282063EFO_0008416
Diseasecholesterol in large VLDL measurement

STX1A DNAH10 COBLL1 JMJD1C

1.12e-03652064EFO_0021902
Diseaseneutrophil percentage of granulocytes

TRERF1 IL18RAP TRMT10C TRIM31 RFX6 HIVEP3 PRKDC

1.15e-032282067EFO_0007994
Diseasediet measurement

SOX5 TRIO CHD2 DNAH14 TMCO4 DST NGEF ABCG2 FERMT3 RARB KIF26B RTN4 ACTR3B JMJD1C INF2 PRKDC L3MBTL4

1.17e-03104920617EFO_0008111
Diseaseserum alanine aminotransferase measurement

ERBB3 MARK3 CD2AP NARS1 PARVB CMYA5 AHNAK UBD ZCCHC8 WWP2 COBLL1 PCLO PRPF3 SUGP1 PATJ

1.23e-0386920615EFO_0004735
Diseasetotal lipids in large VLDL

STX1A DNAH10 COBLL1 JMJD1C

1.25e-03672064EFO_0022175
Diseaseatrial fibrillation

SOX5 NACA CATSPER3 DNAJC12 MLLT3 DNAH10 ACAD10 JMJD1C ZFHX4

1.26e-033712069EFO_0000275
DiseaseOvarian Mucinous Adenocarcinoma

ERBB3 CDK14 WEE2

1.31e-03312063C1335167
DiseaseEmbryonal Rhabdomyosarcoma

DMD SETD2

1.32e-0382062C0206656
Diseasefree cholesterol in large VLDL measurement

STX1A DNAH10 COBLL1 JMJD1C

1.33e-03682064EFO_0022265
Diseasefree androgen index

SOX5 ZNF318 DENND2D URB1 COBLL1 JMJD1C SETD2 ZFHX4 EPAS1

1.33e-033742069EFO_0007005
Diseaseage at menopause

BIRC6 TNRC18 BOD1L1 DOCK10 INO80 ZFHX4 CSF3R PRKDC

1.34e-033022068EFO_0004704
Diseasetriglycerides to total lipids in very small VLDL percentage

PRAM1 STX1A COBLL1 JMJD1C

1.40e-03692064EFO_0022341
Diseaseprostate cancer (is_implicated_in)

BRCA2 CCNB1 EGFR IKBKB CDC25A

1.41e-031172065DOID:10283 (is_implicated_in)
Diseaseurate measurement, bone density

DDX59 CD2AP CATSPER3 DNAH14 FSIP2 KIDINS220 SEC16A UTRN AHCTF1 PPL AKAP12 PRKDC

1.45e-0361920612EFO_0003923, EFO_0004531
DiseaseHead and Neck Neoplasms

ERBB3 RARB EGFR

1.57e-03332063C0018671
Diseasesugar consumption measurement

TRIO MAP4 TRMT10C RARB L3MBTL4

1.57e-031202065EFO_0010158
Diseasesymmetrical dimethylarginine measurement

AKR1B10 AKR1B15

1.69e-0392062EFO_0006523
DiseaseGlioma

BRCA2 SUFU

1.69e-0392062cv:C0017638
DiseaseGout

ABCG2 IL1B

1.69e-0392062C0018099
Diseaseplatelet measurement

CD2AP DENND2D TASOR RTN4 DOCK10 ACAD10 JMJD1C MYB

1.75e-033152068EFO_0005036
Diseaseintellectual disability (implicated_via_orthology)

ZNF280D KDM5C BOD1L1 NAA15

1.90e-03752064DOID:1059 (implicated_via_orthology)
Diseasebody surface area

SOX5 ERBB3 NOG TASOR UNC79 RARB ACAD10 NCOA7 GIGYF2 LTBP1 PATJ PARD3

1.98e-0364320612EFO_0022196
DiseaseParkinson's disease (is_implicated_in)

A2M PHACTR2 GIGYF2 IL1B

2.00e-03762064DOID:14330 (is_implicated_in)
DiseaseDuchenne muscular dystrophy (implicated_via_orthology)

CTNNAL1 DMD UTRN

2.02e-03362063DOID:11723 (implicated_via_orthology)
Diseasemedulloblastoma (is_implicated_in)

BRCA2 SUFU

2.10e-03102062DOID:0050902 (is_implicated_in)
DiseaseInherited focal segmental glomerulosclerosis

CD2AP INF2

2.10e-03102062cv:CN327126
Diseasetauopathy (implicated_via_orthology)

MAP4 CD2AP

2.10e-03102062DOID:680 (implicated_via_orthology)
DiseaseHead and Neck Carcinoma

ERBB3 EGFR

2.10e-03102062C3887461
DiseaseFocal segmental glomerulosclerosis

CD2AP INF2

2.10e-03102062cv:C0017668
Diseaselip morphology measurement

NOG FMN1 PCDH15 DMD ABCC12 EPAS1

2.19e-031892066EFO_0007845
Diseasemean platelet volume

HAUS6 TEX2 CD2AP NACA DENND2D DNAJC12 TASOR FERMT3 PCDHGA2 NUMA1 DOCK10 JMJD1C SETD2 LTBP1 SDHAF4 MYB

2.25e-03102020616EFO_0004584
Diseasewaist-hip ratio

NOG ZNF280D ZNF318 BIRC6 KIDINS220 AHNAK PRUNE2 DNAH10 WWP2 COBLL1 ZNF407 JMJD1C PPL LRRC3B RNF146 DNAH17 PATJ LONRF2

2.49e-03122620618EFO_0004343
Diseasealcohol use disorder (implicated_via_orthology)

ERBB3 KDM5C RYR3 UNC79 JMJD1C EGFR

2.55e-031952066DOID:1574 (implicated_via_orthology)
Diseaseglomerulosclerosis (implicated_via_orthology)

INF2 IL1B

2.56e-03112062DOID:0050851 (implicated_via_orthology)
Diseasegallbladder neoplasm

ERBB3 EGFR

2.56e-03112062C0016978
DiseaseHereditary Nephrotic Syndromes, Autosomal Dominant

CD2AP INF2

2.56e-03112062cv:CN043612
DiseaseMalignant neoplasm of gallbladder

ERBB3 EGFR

2.56e-03112062C0153452
DiseaseAgents acting on the renin-angiotensin system use measurement

ZNF318 AKR1B10 ALDOA TASOR FERMT3 INO80 SF3B3 CDC25A

2.56e-033352068EFO_0009931
Diseasegranulocyte percentage of myeloid white cells

MARK3 MAML1 DOCK10 JMJD1C SETD2 CSF3R PRKDC

2.88e-032682067EFO_0007997
Diseaselung non-small cell carcinoma (is_implicated_in)

ERBB3 RARB EGFR IL1B EPAS1

2.98e-031392065DOID:3908 (is_implicated_in)
DiseaseAutism Spectrum Disorders

SOX5 CHD2 RARB NEMF

3.01e-03852064C1510586
Diseasedickkopf‐related protein 1 measurement

JMJD1C SUFU

3.06e-03122062EFO_0010620
Diseasereticulocyte measurement

DENND2D BIRC6 AHNAK FERMT3 OXR1 DNAH10 ZCCHC8 COBLL1 TRIM31 USP37 JMJD1C SH3D21 PACS1 DNAH17 NCOA7 ASXL2

3.08e-03105320616EFO_0010700
DiseaseChildhood Medulloblastoma

BRCA2 KAT6A SUFU

3.37e-03432063C0278510
DiseaseMelanotic medulloblastoma

BRCA2 KAT6A SUFU

3.37e-03432063C1275668
DiseaseMedullomyoblastoma

BRCA2 KAT6A SUFU

3.37e-03432063C0205833
DiseaseDesmoplastic Medulloblastoma

BRCA2 KAT6A SUFU

3.37e-03432063C0751291
DiseaseAdult Medulloblastoma

BRCA2 KAT6A SUFU

3.37e-03432063C0278876
DiseaseFamilial idiopathic steroid-resistant nephrotic syndrome

CD2AP INF2

3.60e-03132062cv:C4273714
DiseaseMalignant Head and Neck Neoplasm

ERBB3 RARB EGFR

3.60e-03442063C0278996
Diseaseneutrophil count

TRERF1 KDM5C MAML1 SAMD15 KIDINS220 SUPT5H DNAJC12 PRUNE2 OXR1 COPA JMJD1C AKAP12 HIVEP3 SETD2 CSF3R SBNO1 PRKDC IL1B MYB

3.90e-03138220619EFO_0004833
Diseaseneutrophil percentage of leukocytes

MARK3 DENND2D HELZ COBLL1 RFX6 JMJD1C SETD2 CSF3R SBNO1 PRKDC MYB

3.92e-0361020611EFO_0007990
Diseasehair colour measurement

SOX5 ILF3 MARK3 CDK14 AHNAK NGEF DOCK10 AKAP12 ASXL2 PARD3 MYB

4.16e-0361520611EFO_0007822

Protein segments in the cluster

PeptideGeneStartEntry
LSELKKEAPAKEQEP

ZNF280D

736

Q6N043
KEAPAKEQEPVSKEI

ZNF280D

741

Q6N043
LKDVPSSEQPELFLK

PPP2R5E

51

Q16537
SIEPLDPSEKANKVL

ERBB3

686

P21860
TKLKEEPEELAQLAP

EPAS1

391

Q99814
DLSNFEILAKVEPPK

BIRC6

916

Q9NR09
APPLSSLEKDKEIDL

BIRC6

2471

Q9NR09
LEDLPQEKPQSLEKV

CATSPER3

381

Q86XQ3
KAPEDKIESLPKDTD

CRYBG3

546

Q68DQ2
IPLVPDEELDALKIK

BCR

776

P11274
EPKQSTEKPEETLKR

AKAP12

231

Q02952
EKKKSTLPPFDDIVD

MLLT3

346

P42568
PALTPEQKKELSDIA

ALDOA

6

P04075
PPEQSLETAKAIKEK

ACTR3B

216

Q9P1U1
SEKEIQKLPENSPSK

ERO1B

416

Q86YB8
LEKLPELKPVDKESE

ABCF3

461

Q9NUQ8
TEIIEPSKQDKPLIE

ABCG2

316

Q9UNQ0
PTAPLSKLEELKEQE

EIF4EBP3

71

O60516
KEKNKEPLLEESLPA

CFAP46

1546

Q8IYW2
RKPNEKELIELEPDS

COX10

111

Q12887
ASTAEKTEQKEPKPL

DNAJC12

141

Q9UKB3
SPSPLIEDLKEKAKA

ACAD10

696

Q6JQN1
PSLLEDPKIKEIAAK

AKR1B10

226

O60218
PKLKTDVDVSLPKVE

AHNAK

1591

Q09666
LFNKEDEDKLLPSEP

C1orf232

71

A0A0U1RR37
DSVIKPLDTIPEDKK

CDK14

56

O94921
PEEKDEKSTLEQKPS

CD2AP

366

Q9Y5K6
LPKEEDSANLKPSEL

CD2AP

521

Q9Y5K6
APISPEEQDKLENKL

DMD

2281

P11532
ALIKDPDKEIDELIP

ANKRD17

1791

O75179
LSEVPKVEAENISPK

COBLL1

426

Q53SF7
DIEDLKKEAANLPPE

ECD

396

O95905
EKSLEELTKLVPPEC

ATP2C2

156

O75185
SILPIKCPKDEDLLE

ASXL2

476

Q76L83
KCPKDEDLLEQKPVT

ASXL2

481

Q76L83
KPLLVEPEGLEKETT

A2M

901

P01023
KPLVLKEEPTIEDET

CCNB3

156

Q8WWL7
EEPSIEKEAVLKEPT

CCNB3

806

Q8WWL7
TPLEKDELKPFDILQ

RAI2

281

Q9Y5P3
KKPEDSPSDDDVLIV

RANBP2

2621

P49792
LTPLSSELDPEVQKK

RBM44

126

Q6ZP01
LPEDLPFKLEKSVDN

PCDHGA2

386

Q9Y5H1
DLEEPTKVDKLQEPL

RARB

341

P10826
EPEKVDKLQEPLLEA

RARG

346

P13631
LENLPEALTDKKIPI

RFX6

361

Q8HWS3
PLKVIESEKLDEAPE

FMN1

421

Q68DA7
PDTLKPKEVVSLLLD

INO80

1256

Q9ULG1
EESLKSPLKPESQLD

PARP2

221

Q9UGN5
LDKEILLKIPESITP

PCDHB2

136

Q9Y5E7
SLNKELKQEPVEDLP

MAML1

211

Q92585
DDKPTLQLESVDPKN

IL1B

191

P01584
DTKLKPDILDPVEDT

IL18RAP

246

O95256
SKNIPTTKDVEPLLE

KIDINS220

1006

Q9ULH0
TKDKALPLEAEVAPV

MAP4

461

P27816
EDQVPALKTEAPLAK

MAP4

546

P27816
KREIKPSLEADKPVE

NEMF

251

O60524
NSLPEPAKKSEELVA

IKBKB

696

O14920
PDLVKLLTPDEIKQS

KCTD16

116

Q68DU8
ADPPATEKTLLEEKV

GRPEL1

51

Q9HAV7
LKDVLPPIIKDTESE

DST

2706

Q03001
KDKLTELLEENPDTP

DST

4576

Q03001
EPDKPIVKKSIDELN

DST

6231

Q03001
IPPEQSLETAKAIKE

ACTR3C

86

Q9C0K3
EKPKASPDNLLILSE

KIF26B

1331

Q2KJY2
TSKINVKPELKEEPE

JMJD1C

2126

Q15652
VKPELKEEPEESIIS

JMJD1C

2131

Q15652
KPDPEDLQLDKSRDV

DDX59

26

Q5T1V6
KVREEIKSEPSKPDD

FSIP2

5756

Q5CZC0
KKLLPEAKTSAPEEQ

PCLO

1246

Q9Y6V0
EIPSLIPTDEKDILK

PCLO

1376

Q9Y6V0
DKLLKDLPELALDTP

PDCD4

241

Q53EL6
VLKELDTPPNVEKAL

PLXNA3

1316

P51805
IEQPIIEEKPSLSSK

KIAA1586

111

Q9HCI6
KEIPSLDQEKTKLEP

LTBP1

806

Q14766
LDLDPLSKPKVDNVE

PIK3C2A

271

O00443
VPPDKDLLALEQSKT

PDPR

486

Q8NCN5
TDLEENPKKPIEDVL

PDCL3

206

Q9H2J4
EVLKKVPDPVLEESF

PPL

936

O60437
TLKALRPKAQPEEED

FKBP15

1176

Q5T1M5
DVIQALEEKKPTPKE

METTL16

401

Q86W50
QAEEEKKPKDSTTPL

L3MBTL4

26

Q8NA19
SLPSRQKKADEPDDI

LRRC3B

241

Q96PB8
PLLKKIKQEVESPTD

MYB

521

P10242
EPPVVTLLDKKEGEQ

LRRC8E

216

Q6NSJ5
EEDKKALESILPTAP

LONRF2

381

Q1L5Z9
SEKTPPLEEQAEDKK

PHACTR2

126

O75167
EAPVPSILKKILLEE

NR0B2

111

Q15466
TVKPPEDQLKSENLE

HELZ

1836

P42694
QKEREKPLPTFKDLD

PIP5K1A

271

Q99755
EEVPPDSDDNKTKKL

INF2

1231

Q27J81
ELIPEKLAKVETPLE

NAA15

641

Q9BXJ9
ETPLEEAIKFLTPLK

NAA15

651

Q9BXJ9
DLFPPKELVKEEENL

MTMR4

16

Q9NYA4
EETESILSTPKPKLK

PACS1

386

Q6VY07
IDPTSKEDPKFKELV

PARVB

76

Q9HBI1
FSLPEEDTKLKIPLI

GBA

186

P04062
IAPEKSVPDDTKLVN

HFM1

136

A2PYH4
KVTEDPELKLIPFSL

OR7G1

16

Q8NGA0
KEPDVSEELDTKLPL

PARP14

116

Q460N5
PSELLLPDQIEKLTK

OXR1

711

Q8N573
KPKIQESEETVEPKE

KAT6A

1201

Q92794
PPTLVEKKIEDLTEI

PCDH15

1256

Q96QU1
EKPEREKTPSEDKLS

BOD1L1

726

Q8NFC6
EAEKDSPLTTEIPNK

C6orf132

901

Q5T0Z8
PLDPQELDILKTVKE

EGFR

386

P00533
KEEKLSPEPILVDTA

CCNB1

111

P14635
LLEPESVIKPFEEKA

DOCK10

376

Q96BY6
SLKPDKPDSEEQAKI

CTNNAL1

551

Q9UBT7
FLSLKKVQKEPIPEE

GIGYF2

306

Q6Y7W6
SLPKSEKPLNEETVV

BRCA2

451

P51587
KKLVESEAPEKEIFP

DNAH17

3801

Q9UFH2
TDPELKLTDKILPVE

CHD2

1286

O14647
EKKDPSALKEREVPQ

FCF1

36

Q9Y324
EKETIPDIDPNAKLL

COPA

781

P53621
KNLEELEEKSTTPPP

G3BP2

216

Q9UN86
SVLPDSVPAIKKEQE

CMYA5

1171

Q8N3K9
DDAAIVIKNTKEPPL

ILF3

151

Q12906
PPITKLTVLEEDEKK

CSF3R

691

Q99062
KPLETQPAEIAEKET

DNAH14

216

Q0VDD8
DAFKAIKTEKLEEPP

ELK3

156

P41970
PDILKTESLLPKLDA

MAP3K12

506

Q12852
LKPFVEPELDISDQK

MARK3

316

P27448
KDPTQPILEALDKDS

IFNGR2

296

P38484
LKKDEDIPLFPVQTK

DDX24

706

Q9GZR7
EEDILNKSLDAKEPP

HAUS6

936

Q7Z4H7
EISLDDESPKNPQKK

KIAA1210

331

Q9ULL0
PNLPLVSEEEKSITK

KIAA1210

466

Q9ULL0
LKLPEEKEETIPKAV

HEATR1

1471

Q9H583
VLKESVDLPEEKLPI

AHCTF1

1496

Q8WYP5
LFPPDAEKELVDKIE

DNAH10

1141

Q8IVF4
QTKPTEKILELPDET

SAMD15

396

Q9P1V8
EKILELPDETKPRET

SAMD15

401

Q9P1V8
KIPAQTKSPEETDKE

SDC2

96

P34741
LEKFPDDVNPVTKEK

SDHAF4

71

Q5VUM1
ILPEKATPLSIKEQE

SACS

3706

Q9NZJ4
KLEKLAEDLPPNTLD

SBNO1

861

A3KN83
DEKDILPPKLQDDIL

DENND2D

341

Q9H6A0
ELKDQTKPTPLILDE

PRPF3

246

O43395
EEVEDFLLKKPIVPT

CDC25A

406

P30304
EKQAASPLEPKELEE

NUMA1

266

Q14980
SPLEPKELEELRDKN

NUMA1

271

Q14980
PLSLKKEIPENSAVD

OVGP1

661

Q12889
PKETKAEDEDIVLTP

PARD3

566

Q8TEW0
DPIFDPKEKDLNETL

NOG

51

Q13253
VPIIENTPEEKDLKD

APIP

161

Q96GX9
PDEVSTLSKKEKIPL

RTN4

816

Q9NQC3
RIPLPELKDSDKLDK

TAF5

426

Q15542
PKLVPEETTLEKTAD

SPATA48

256

A4D263
KLLDPEDVAVQLPDK

UTRN

226

P46939
PLQADKEDPISKSEI

RPE65

211

Q16518
TAKPPKEILKEADTD

TRMT1L

221

Q7Z2T5
TPVPLELEKKLSEAK

TRIM31

266

Q9BZY9
AAKVPEVELKDLSPS

AHCYL2

11

Q96HN2
EKTIPTKEPEQIKSE

PRUNE2

2516

Q8WUY3
VASKEEVTLKEELPP

SH3D21

506

A4FU49
EVTLKEELPPKEEVA

SH3D21

511

A4FU49
QILLKDPILKDDPTV

TMCO4

101

Q5TGY1
NEKFAPELLESKPEI

GINS4

36

Q9BRT9
EEAKKITIKNDPSLP

NARS1

96

O43776
IEDILPSKEEKSKTP

NCOA7

641

Q8NI08
GEPTTLTKEEEKKQP

OGA

446

O60502
KAIKLFLTPEDLDDP

PUS7L

456

Q9H0K6
EPSELIKVLGEKPEL

SCIN

216

Q9Y6U3
LPKVLEVDEKSPEAK

PIRT

6

P0C851
ANIPDIALEPDKTVK

PIK3C3

826

Q8NEB9
KPELLPEKEETSQAD

NGEF

31

Q8N5V2
EVTDLPKKPSKLELS

PRAM1

111

Q96QH2
VLSEKSADKIPEPKE

PRRC2C

2071

Q9Y520
LKKLIDLESPTPESQ

SIPA1L1

1541

O43166
DFLDKPTLLSPEELK

RNF146

81

Q9NTX7
DEELKSQPEPLVVKG

SELENBP1

366

Q13228
EDAIVEVTPKLPKES

SLC41A2

141

Q96JW4
VKPTLSELEKFEDQP

SUPT5H

386

O00267
ATEDAKPVKIKEEPV

SUPT7L

266

O94864
KVIEFDKPEVLAEKP

ABCC12

1331

Q96J65
LPPEDTQELIFKDKS

URB1

1616

O60287
APIPEPKTKDDLEQL

STX3

66

Q13277
LLEPSVKIETKDVPL

SOX30

301

O94993
AFLPIKLPEKLDVET

TASOR

381

Q9UK61
PSLLEDPKIKEIAAK

AKR1B15

226

C9JRZ8
EELKADVVPVTLAPK

CLSPN

566

Q9HAW4
SPPEDEEVKNLAEKL

SUGP1

256

Q8IWZ8
TPEDEEIPKVSTKLL

XIRP2

176

A4UGR9
VEKKDLELEKEAPSP

TNRC18

1056

O15417
AEETNVLPKEKQTKP

PDCD11

1511

Q14690
KIDPLLPKEVKNEES

MRPL1

306

Q9BYD6
LTLKVVKPSDEELPL

UBD

76

O15205
SDDEQEKKPEAPKLS

SF3B2

436

Q13435
LLVPKTEICEEAEKP

ZNF35

121

P13682
ISEKPEKPKQEFISE

ZFHX4

1816

Q86UP3
NKRPTLKDLESIDPE

WWP2

636

O00308
KTSEKQTLDEPEVPE

ZCCHC8

571

Q6NZY4
FPKPNLDITEEIKED

RNPC3

366

Q96LT9
DLVTEALDTKVPLPK

SLC16A13

406

Q7RTY0
QLKEKPEEESLAAPT

SEC16A

1861

O15027
LEKVPDSPENELKSR

PATJ

516

Q8NI35
SDVKLLPPQEILVDK

RYR3

971

Q15413
LPKSEKKAQQTPTEE

SOGA3

506

Q5TF21
ILASPNPDEKTKEEL

STX1A

61

Q16623
LEKRLTLEPKPDTDK

TTBK2

451

Q6IQ55
KAPEETIQSKKEDLP

TXNDC2

121

Q86VQ3
KAPEETIQSKKEDLP

TXNDC2

181

Q86VQ3
KEDLPKSSEEAIQPK

TXNDC2

191

Q86VQ3
TIQPKEDDSPKSLEE

TXNDC2

411

Q86VQ3
DLEDLTSPEEFKLPK

SUFU

446

Q9UMX1
SPISKEKLPNAETEK

TMEM186

41

Q96B77
KPSDEVEPKESELTK

HIVEP3

616

Q5T1R4
LTPLSVKKEDSKEQP

HIVEP3

1546

Q5T1R4
VKKEDSKEQPDLPSL

HIVEP3

1551

Q5T1R4
PKAEELLSKAVKLEP

TTC5

86

Q8N0Z6
FETLKTPDIDVPKEN

WDR44

266

Q5JSH3
LKKAKDVIEDNPDEP

ZDBF2

1801

Q9HCK1
LPPDKKSKIEVSTEE

PHF3

1376

Q92576
PEELSLLRAPEKKEK

FERMT3

136

Q86UX7
AVESIQDSPLPKKAE

TBCC

161

Q15814
ELDRTPPEVSKKLED

SF3B3

1196

Q15393
LNDSPTLKKLDELPI

SETD2

621

Q9BYW2
SKIEEKLTPLPEDNS

PRKDC

3191

P78527
KPFNLEIAPELSEKI

ZNF658

121

Q5TYW1
KDSKLCPIEPDKSEL

USP37

681

Q86T82
KNEPEETPSIEKLLS

SOX5

156

P35711
EKDKESPDQILRTPV

WEE2

71

P0C1S8
AAALAEEPLVKEKPL

ZNF407

1836

Q9C0G0
VDKLSDIPLKPEVLA

TEX2

436

Q8IWB9
LKEAQSEKEEAPKPL

TOPBP1

891

Q92547
KNESTPPSEELELDK

TRMT10C

51

Q7L0Y3
KSEKENDPLRTPEAL

ZFC3H1

756

O60293
SPEKPKTEALELQDV

ZNF318

1971

Q5VUA4
IEELKVKIPSNPLEA

ZMYM3

916

Q14202
LKPENILVDESLAKP

TRIO

2916

O75962
PVKPAPKEDLDLIDL

UNC79

1596

Q9P2D8
PLDQLSLIKPIKDVD

TRERF1

1146

Q96PN7
TEELKPELLLPKDNS

INSYN2B

271

A6NMK8
PELLLPKDNSDDKDL

INSYN2B

276

A6NMK8
EPTEEDIEKNPELKK

KDM5C

221

P41229
DPEDLKNLPSSVLVK

NACA

511

E9PAV3